Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
EUROBAROMETERMEDICAL
AND HEALTH RESEARCHA special Eurobarometer public survey
EUR 22970
EUR
OB
AR
OM
ETER
ISSN 1018-2249
Interested in European research?
Research*eu is our monthly magazine keeping you in touch with main developments (results, programmes, events, etc.). It is available in English, French, German and Spanish. A free sample copy or free subscription can be obtained from:European Commission Directorate-General for ResearchCommunication UnitB-1049 BrusselsFax (32-2) 29-58220E-mail: [email protected]: http://ec.europa.eu/research/research-eu
EUROPEAN COMMISSIONDirectorate-General for ResearchDirectorate F — Health1Unit F.1 — Horizontal aspects and coodination
Contact: Josefina Enfedaque
European CommissionOffice CDMA 2/180B-1049 Brussels
Tel. (32-2) 29-58605Fax (32-2) 29-95888E-mail: [email protected]
Cover photo: Human male karyotype. A standard arrangement of the whole set of chromosomes of one cell, done for chromosome analysis. In humans, the normal chromosome complement consists of 46 chromosomes. Copyright: ©2003 Image DJ Corporation
EUROPEAN COMMISSION
Medical and Health ResearchA special Eurobarometer public survey
2007 EUR 22970 EN
A report produced by
TNS Opinion & Social
for
the Directorate-General for Research
coordinated by
the Directorate-General for Communication
Directorate-General for ResearchCooperation/Health
LEGAL NOTICENeither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information.The views expressed in this publication are the sole responsibility of the author and do not necessarily reflect the views of the European Commission.
A great deal of additional information on the European Union is available on the Internet.It can be accessed through the Europa server (http://europa.eu).
Cataloguing data can be found at the end of this publication.
Luxembourg: Office for Official Publications of the European Communities, 2007
ISBN 978-92-79-06625-2
© European Communities, 2007Reproduction is authorised provided the source is acknowledged.
Printed in Luxembourg
PRINTED ON WHITE CHLORINE-FREE PAPER
EUROPE DIRECT is a service to help you find answers to your questions about the European Union
Freephone number:00 800 6 7 8 9 10 11
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed
Special EUROBAROMETER 265 “Medical and health research”
1
Table of contents
INTRODUCTION........................................................................................ 2
1. INTEREST IN MEDICAL AND HEALTH RESEARCH ................................... 4
1.1. GENERAL INTEREST................................................................. 4
1.2. SPECIFIC INTERESTS............................................................... 9
1.2.1 The aspects of biological and medical research 9 1.2.2 The aspects of specific research into a major disease 10
2. AWARENESS OF COLLABORATIVE RESEARCH PROJECTS FUNDED BY THE EUROPEAN UNION.................................................................................. 18
3. ACCESS TO INFORMATION ON RESEARCH........................................... 23
3.1. INFORMATION ON EUROPEAN CO-FUNDING .......................... 26
3.2. USE OF SOURCES OF INFORMATION ...................................... 28
3.3. RELIABLE SOURCES OF INFORMATION .................................. 31
CONCLUSION.......................................................................................... 35
ANNEXES Technical specifications Questionnaire Tables
Special EUROBAROMETER 265 “Medical and health research”
2
INTRODUCTION Biological and medical research is an important part of European research, which is at the heart of the European Union’s plan for growth and employment. A debate on increased investment in research was recently launched within the context of the new framework programme for research covering the period 2007-2013 and adopted on 6 April 2006 by the European Commission1. The increase in investment in research translates the approach adopted in the Lisbon Strategy, namely to make the European Union progressively the most competitive and dynamic economy in the world. Such increasing investment should be accompanied by greater efforts in the field of research. This will involve above all making better use of the European Union’s capacity in this area and ensuring greater success in transforming research results into new products, services and processes. Moreover, the EU is attempting to eliminate obstacles to cooperation between scientists from different countries. Indeed the European research area was created to that end within the framework of the fifth framework programme for research. The launch by the European Commission in 2004 of the world’s leading network for research into diseases caused by prion2 (including Creutzfeldt-Jakob disease) is one of the major European successes in the field of biological and medical research. The continuous launch of collaborative medical and health research projects funded by the European Union is another success story3, with research into genomics and biotechnology for health being two of the priorities of the current sixth framework programme for research. These initiatives translate the Lisbon Strategy, but are also important from the point of view of public health because they provide or may provide solutions to the health problems of numerous European citizens, by meeting the following objectives: a) to continue deciphering the genomes of living organisms in the interest of public health and to enhance the competitiveness of the European biotechnology industry; b) to develop new tools for the diagnosis and treatment of chronic and life-threatening diseases; c) to combat cancer and diseases linked to age and poverty4. It was in the above context that the Directorate General for Research commissioned the Eurobarometer special study on medical and health research. The study was carried out between 7 June and 12 July 2006 among 24,796 people in the 25 European Union Member States as well as in the acceding countries (Bulgaria and Romania)5. In Turkey and Croatia, the study was carried out between 17 November and 19 December among 2,005 respondents that same year.
1 http://ec.europa.eu/research/press/2005/pr0704-2en.cfm 2 For more information, consult: http://ec.europa.eu/research/infocentre/article_en.cfm?id=/comm/research/press/2004/pr2805en.cfm&item=Health%20%26%20life%20sciences&artid=704 3 For more information, consult: http://cordis.europa.eu/lifescihealth/projects.htm 4 http://ec.europa.eu/research/fp6/index_en.cfm?p=1 5 The technical note contains more details on the methodology used and specifies the interview arrangements as well as the intervals of confidence.
Special EUROBAROMETER 265 “Medical and health research”
3
The study’s aims were in particular:
to measure the level of awareness among European citizens of European collaborative research projects on biological and medical issues and their awareness of European Union co-funding. Furthermore the study sought to put this information in the more general context of citizens´ interest in science and technology and biological and medical research, also taking into account personal and socio-economical factors;
to identify factors which raise awareness of European collaborative research
projects on biological and medical issues and of European co-funding, to generally contribute to improving the strategy of promoting those research
projects which are funded by the European Union. Furthermore, in the last part of this study we analyse three different groups of citizens:
those aware of European biological and medical research projects and the fact that they are co-funded by the EU,
those not aware of the projects but who are interested in the field of science
and medical research,
those not aware of the projects and who also have no interest in the field of science and medical research.
This analysis of three distinct groups is carried out in order to get a clearer picture of the factors influencing citizens’ awareness of European collaborative research projects on biological and medical issues. It also examines their awareness of European co-funding of research and how interested they are in science and health issues. This report sets out the study’s main conclusions. For each part, the results are analysed at European Union level and, where necessary, on a country basis. Where applicable, a brief socio-demographic analysis is included6.
6 In certain cases, the total proportions may fluctuate by one percent in relation to the proportions of the individual categories owing to the rounding of figures.
Special EUROBAROMETER 265 “Medical and health research”
4
1. INTEREST IN MEDICAL AND HEALTH RESEARCH In this chapter, we will present first of all an overview of the interest of European citizens in medical research and in science and technology, before describing in greater detail the specific aspects of their interest.
1.1. GENERAL INTEREST - Three out of four Europeans are interested in medical and health research
and three out of five in science and technology - Questionnaire source: QC1, QC8 In order to measure the interest of Europeans in medical and health research on the one hand, and in science and technology on the other hand, the respondents were asked to assess their level of interest in various topics7. As can be seen from the chart on the next page, a considerable number of Europeans are interested in these two topics: 71% of citizens are interested in medical and health research, while 60% stated that they are interested in science and technology. It is noteworthy that the environment represents the main centre of interest of Europeans (84%). Moreover, Europeans are slightly more interested in medical and health research (71%) than in European and international news (70%) and economic and social affairs (68%) - subjects which are traditionally of interest to large sections of the population.
7 QC1. For each of the following topics, please tell me if you are very interested, fairly interested, not very interested, or not at all interested…
Special EUROBAROMETER 265 “Medical and health research”
5
QC1 For each of the following topics, please tell me if you are very interested, fairly interested, not very interested, or not at all
interested. Answer: 'very interested + fairly interested'
EU25
84%
71%
70%
68%
66%
66%
60%
52%
42%
Nature and the environment
Medical and health research
European and international news
Economic and social matters
Sports and outdoor activities
Home and gardening
Science and technology
Art and literature
Celebrities and entertainment
Analysis of the results by country There is strong interest in most European countries, particularly in the old EU Member States, in health research and in science and technology. Almost all citizens in Greece declared that they are interested in these topics (93% for medical and health research and 82% for science). This is also the case for a significant majority of citizens in France (85% and 66%) and Luxembourg (84% and 68%). However, citizens in the new Member States and the two acceding countries seem relatively less interested in these subjects, in particular in the Czech Republic (50% are interested in research and 40% in science and technology), Lithuania (47% and 43% respectively) and Romania (53% and 41% respectively). In Turkey, interest in these topics is generally relatively low, with only 46% being interested in medical and health research and 40% being interested in science and technology.
Special EUROBAROMETER 265 “Medical and health research”
6
Special EUROBAROMETER 265 “Medical and health research”
7
The differences between the old Member States [EU15], the new Member States [NMS] and the acceding countries [AC] in terms of interest in these topics seem to be based more on socio-demographic specificities than cultural characteristics. The socio-demographic profile of the new Member States and the acceding countries is different from that of the old Member States, where the levels of interest are high: the population studied in the new Member States and the acceding countries is slightly younger (28% of people aged 55 and over in the NMS and 30% in the AC compared with 34% in the EU15), less educated (21% of the people who finished their studies at the age of 20 and over in the NMS compared with 24% in the EU15) and often having less personal experience of a chronic or life-threatening disease8 (46% in the NMS and 29% in the AC compared with 51% in the EU15). Now, as we will see in the socio-demographic analysis, there is a link between these variables and the respondent’s interest in science or medical and health research. Socio-demographic analysis Overall, there is a positive correlation between the level of education of citizens and their interest in most of the topics: the higher their level of education, the more the respondents are interested in the various topics, except for gardening and celebrities. More specifically, science and technology arouse more interest among certain categories of the population, in particular depending on the gender, education and, consequently, profession of the respondent. Men (71%) and people who finished their studies at the age of 20 and over (73%) are more likely to be interested in these topics than women (49%) and less well-educated people, i.e. those who left school at the age of 15 or before (46%). A more detailed analysis shows that the differences noted between men and women as regards their interest in these topics are not linked to a difference in the level of education according to gender: among the group of European citizens with the highest level of education (those who finished their studies at the age of 20 and over), science and technology are subjects which are of less interest to women (61%) than men (83%). It is also noteworthy that young people are more interested than older people in science and technology (64% for the 15-24 age group versus 54% for those aged 55 and over). The differences noted in terms of the respondent’s education are accompanied by differences in the level of interest according to the respondent’s occupation: managers – professions which usually require a higher level of education – are more interested in science and technology (76%) than manual workers (57%). Medical and health research, while being of greater interest to people with a higher level of education (77% in comparison to 70% of people who left school at the age of 15 or before) arouses greater interest among women (75%) than among men (67%). Furthermore, respondents who have had or whose loved ones have had a chronic or life-threatening disease are more interested in medical and health research (77% in comparison to 66% for those who have not had any personal experience of such a disease) and, to a certain extent, in science and technology (61% versus 58% for those who have not experienced such a situation).
8 QC8 Have you or any of your loved ones, have or have had a chronic disease (asthma, diabetes, etc.) or a life-threatening disease (aids, cancer, etc.)?
Special EUROBAROMETER 265 “Medical and health research”
8
Moreover, unlike science and technology, the interest of citizens in medical and health research increases with age (76% of people aged 55 and over compared with 61% of those aged 15-24). As we noted above, interest in this subject is also linked to the respondent’s personal experience of a chronic or life-threatening disease. Logically, the proportion of respondents affected by this type of disease increases with age (44% of the 15-24 age group, 46% of the 25-39 age group, 52% of the 40-54 age group and 56% of those aged 55 and over).
Age x Chronic physical or mental problem
15-24 25-39 40-54 55 + Interest in medical and health research
Yes No Yes No Yes No Yes No
Interested 65% 58% 77% 63% 80% 68% 79% 72%
Not interested 35% 42% 23% 37% 20% 32% 20% 28%
The stronger interest among older people cannot be explained solely by the fact that such respondents have been more frequently confronted with a chronic or life-threatening disease (either themselves or their loved ones). Consequently, it is difficult to determine whether the higher level of interest among seniors is an effect of age or an effect of their personal experience of such diseases. It seems in fact to be a combination of these two factors: respondents who do not have any personal experience of a chronic or life-threatening disease are also more interested in medical and health research when they are older (58% of the youngest age group compared with 72% of respondents aged 55 and over). Symmetrically, in all age groups, the level of interest in medical and health research is the highest among respondents who have been confronted personally with a chronic or life-threatening disease (themselves of their loved ones). Finally, there are no significant differences between respondents according to the areas where they live: the levels of interest in science and technology and medical and health research are similar between respondents living in rural areas (57% and 72% respectively) and those living in large towns (62% and 71% respectively).
Special EUROBAROMETER 265 “Medical and health research”
9
QC5 Certain aspects of biological and medical research might be of more interest to you. How interested are you
in each of the following? Answer: 'very interested + fairly interested'
EU25
78%
65%
57%
The results of the research (what is known)
The launching of research projects and themain objectives of the research (what we
expect to know)
How researchers are trying to get thisknowledge (the way research is carried out)
1.2. SPECIFIC INTERESTS In order to describe in more detail the interest of Europeans in biological and medical research, we asked the respondents to indicate, on the one hand, the aspects of research in general which arouse their curiosity and, on the other hand, their views on the most interesting aspects of specific research into a major disease.
1.2.1 The aspects of biological and medical research
- Three out of four Europeans are particularly interested in the results of biological and medical research -
Questionnaire source: QC5 When asked what aspects of biological and medical research are of particular interest to them, Europeans seem to be more interested in the research results, that is to say the knowledge acquired as a result of the discoveries of researchers, rather than in the research process itself. Almost eight out of ten Europeans (78%) mentioned the research results, compared with 65% who mentioned the research objectives and 57% who mentioned the research methodology. Respondents who have had a chronic or life-threatening disease or whose loved ones have suffered from such a disease are more interested in the end results of the research (82% compared with 75% for those who have not had any personal experience of a serious disease).
Special EUROBAROMETER 265 “Medical and health research”
10
Analysis of the results by country National differences regarding the levels of interest in the causes and treatment of diseases are similar to those noted with regard to medical and health research in general. The results of the research were mentioned more frequently in the old Member States, notably in Greece (98%), Belgium (90%), France (89%) and Luxembourg (89%) – countries where the general interest in biological and medical research is particularly high. Citizens in the new Member States, especially those in the Czech Republic (53%) and Lithuania (36%) are less interested in this research aspect. Socio-demographic analysis The socio-demographic differences are similar to those noted for the general interest question on medical and health research: older people, those with highest level of education and managers are more interested in the different aspects of research. Once again, we have to bear in mind that age and personal experience of a chronic or life-threatening disease are correlated. Accordingly, it is difficult to determine which of the two factors is the most discriminant.
1.2.2 The aspects of specific research into a major disease
- Europeans are particularly interested in new discoveries - Questionnaire source: QC7 Among the aspects inherent in research being carried out into a major disease, new discoveries are of particular interest to Europeans (60%). It is also noteworthy that one in three Europeans would like to know more about the risks of a disease spreading (34%), as well as its causes and treatment (31%). European citizens seem to find other aspects, such as the daily life of researchers (6%) or ethical issues (11%), far less interesting.
Special EUROBAROMETER 265 “Medical and health research”
11
QC7 Imagine that research is being done on a major disease. What aspects of this research would you be the most interested in?
(MAX. 3 ANSWERS)EU25
60%
34%
31%
25%
19%
15%
15%
11%
6%
New discoveries
Researcher’s work on the risks of this diseasespreading
Debates on this disease (causes, treatments,etc.)
Research to improve health care systemmanagement (e.g. in hospitals) for this
disease
Showing materials about the research on thedisease
The Government decisions about the research
Basic research leading to new approaches
Ethical issues about this research
The daily life of researchers working on thistopic
An analysis of the answers to the two previous questions highlights Europeans´ interest in the “pragmatic” aspects of biological and medical research, namely the results of the research. In other words, what interests Europeans in medical and health research is above all the added value that they can obtain from such research, for example information which allows them to better protect themselves from infectious diseases. In order to encourage citizens’ interest in medical and health research the focus of communication should probably be on new research discoveries.
Special EUROBAROMETER 265 “Medical and health research”
12
It is also noteworthy that people who declared that they are interested in medical and health research in general, are more interested in each of the specific research aspects.
GENERAL INTEREST IN RESEARCH SPECIFIC ASPECTS OF
RESEARCH
Interested Not interested
New discoveries 63% 49%
Researcher’s work on the risks of this disease spreading 36% 21%
Debates on this disease (causes, treatments, etc.)
33% 23%
Special EUROBAROMETER 265 “Medical and health research”
13
Analysis of the results by country The results reveal certain specific national characteristics. While the causes and treatment of diseases were mentioned with the same frequency in the new and old Member States, new discoveries seem to be of greater interest to citizens in the old Member States. This aspect was the most frequently mentioned in the Netherlands (77%), Belgium (72%) and Denmark (72%), while citizens in the Czech Republic (47%) and Lithuania (46%) attach less interest to it. Once again, these differences can be partly explained by socio-demographical specificities of the old and new Member States9.
9 As stated on page 7 of this report, the population studied in the new Member States and the acceding countries is slightly younger, less educated and has less personal experience of a chronic or life-threatening disease than the population studied in the old Member States.
Special EUROBAROMETER 265 “Medical and health research”
14
A half of Swedes polled are interested in the work carried out by researchers on the risk of a disease spreading. Also in Finland (47%) and Luxembourg (46%) levels of interest in this aspect of research are relatively high. Overall, most interest in this topic is found in the northern and western parts of Europe – and therefore particularly in certain old EU Member States. Nevertheless, Bulgarians appear to be more interested (55%) in the risk of a disease spreading than citizens from any other EU county. In Latvia (16%) and Spain (21%) however levels of interest in this topic are low.
Special EUROBAROMETER 265 “Medical and health research”
15
Debates on the causes and treatments of a disease are of interest to around half of the citizens of Portugal, Cyprus (both 54%) and Slovakia (52%), whereas levels of interest seem to be fairly low in the Netherlands (18%). As far as the two acceding countries are concerned, levels of interest in this topic are around the EU average in Bulgaria (35%) and beyond average in Romania (45%).
Special EUROBAROMETER 265 “Medical and health research”
16
In Sweden (46%), research to improve health care system management for particular diseases is seen as considerably more important than in any other EU country. This figure stands in contrast to corresponding figures in Poland, Spain, Germany, Lithuania and Estonia where less than one in five of respondents are interested in this specific aspect of research. In the European Union’s acceding countries, interest in this topic is lower than the EU average. The lowest levels of interest can however be found in the Union’s candidate states, Turkey and Croatia (15%).
Special EUROBAROMETER 265 “Medical and health research”
17
Showing materials about research on diseases is mainly appreciated in Slovakia (32%), Greece (31%) and Latvia (30%). In Spain, only very few respondents (9%) seem to be interested in seeing such materials that, for example, visualise what a disease does to the body.
Socio-demographic analysis New discoveries, the aspects relative to the risk of a disease spreading as well as the causes and treatment of a disease were mentioned mainly by the respondents with the highest level of education and by managers. For example, new discoveries were mentioned by 70% of managers, while only 59% of manual workers mentioned this aspect. People who studied up to the age of 20 and over are more likely to be interested in this research aspect (66%) than those who left school at the age of 15 or earlier (55%).
Special EUROBAROMETER 265 “Medical and health research”
18
2. AWARENESS OF COLLABORATIVE RESEARCH PROJECTS FUNDED BY THE EUROPEAN UNION
In this chapter we will analyse how aware European citizens are of collaborative medical and health research projects and the funding of such projects by the European Union. We will then examine the link between the level of awareness of European collaborative research projects and that of the funding of such projects by the EU, and the existence of a relationship between the awareness of such projects and the interest of citizens in medical and health research or science and technology. - Europeans, and more particularly those who are interested in medical and
health research or science and technology, are aware of the existence of collaborative research projects and the co-funding of such projects at
European level - Questionnaire source: QC2a, QC2b Around a half of Europeans (52%) are aware of the possibility for researchers specialised in biology or medical sciences to work on collaborative research projects with European colleagues10. 44% of European citizens have heard of EU co-funding for such projects11.
10 QC2a In (OUR COUNTRY), there are researchers specialised in biology or the medical sciences. Have you ever heard of any of them working on collaborative research projects with colleagues from other European countries, or having the possibility to do so? 11 QC2b And have you ever heard of the European Union funding any collaborative research projects on biology or medical science issues?
QC2a In (OUR COUNTRY), there are researchers specialised in biology or the medical sciences. Have you ever heard of any of them working on collaborative research projects with colleagues from other European countries, or having the possibility to do so?
QC2b And have you ever heard of the European Union funding any collaborative research projects on biology or medical science issues?
Special EUROBAROMETER 265 “Medical and health research”
19
The Pearson coefficient, calculated on the basis of the results of each of the countries studied, reveals a positive correlation between the awareness of European collaborative research projects in the medical and health sector and awareness of European co-funding for such projects12. A cross-tabulation of these two questions confirms this correlation: three out of four Europeans (75%) who are aware of the possibility for national researchers to collaborate with European colleagues on biological and medical research projects have also heard of European co-funding for such projects. Analysis of the results by country In accordance with the previous conclusions, logically, the countries where the most citizens have heard of European collaborative projects in the field of medical and health research13 are also those where the most citizens are aware of the existence of EU co-funding for such projects14. The level of awareness of the existence of EU co-funding for collaborative projects is higher in the old Member States than in the new Member States and acceding countries; this is linked, once again, to the different socio-demographic profiles (higher average age and level of education in the EU15 countries). Citizens are the most aware of European co-funding for such projects in the Netherlands (63%), Finland (62%), Luxembourg (59%) and France (58%) – countries where the levels of awareness of European research projects are among the highest in Europe (72% in France, 68% in the Netherlands, 65% in Finland and 62% in Luxembourg). However, awareness of the EU’s co-funding of these projects is the lowest in Spain (33%), Lithuania (30%), Ireland (25%) and the United Kingdom (22%). In these countries relatively few citizens have heard of European collaborative projects in the field of medical and health research (31% in Spain and in Lithuania, 30% in the United Kingdom and 28% in Ireland). In the acceding countries, Romania and Bulgaria, awareness of co-funding is also low (30% for Romania and 26% for Bulgaria). Meanwhile few citizens in these countries are aware that such research projects exist (37% of Romanians and 28% of Bulgarians). Moreover, knowledge of such projects and their European co-funding differs strongly between the candidate countries of the European Union. While Croatian respondents are more likely than Europeans on average to have heard of such projects and to know that they are funded by the EU, awareness appears to be very limited in Turkey.
12 Pearson = + 0.78. Between -1 and +1, this coefficient measures the importance and direction of the linear relation between two numerical variables. In other words, it measures whether or not there is a relationship (dependency) between the variables. The closer the Pearson coefficient is to +1 or -1, the more significant is the statistical relationship between the variables compared. However, a significant correlation between two variables compared does not mean that there is a causality relationship between them. 13 QC2a In (OUR COUNTRY), there are researchers specialized in biology or the medical sciences. Have you ever heard of any of them working on collaborative research projects with colleagues from other European countries, or having the possibility to do so? 14 QC2b And have you ever heard of the European Union funding any collaborative research projects on biology or medical science issues?
Special EUROBAROMETER 265 “Medical and health research”
20
Special EUROBAROMETER 265 “Medical and health research”
21
In addition, it appears that the interest of citizens in medical and health research or science and technology has a significant impact on their awareness of European collaborative research projects and the co-funding of such projects by the European Union. Moreover, the Pearson coefficient, calculated on the basis of the results in the countries studied, reveals significant positive correlations, on the one hand, between the interest of citizens in science and technology and their level of awareness of European collaborative projects15 and, on the other hand, between the interest of citizens in medical and health research and their level of awareness of such projects16.
15 Pearson = + 0.62 16 Pearson = + 0.45
Special EUROBAROMETER 265 “Medical and health research”
22
A more detailed analysis reveals that people interested in science and technology or medical and health research are more likely to have heard of not only these research projects (58% versus 25% of people who are not interested in these topics) but also of their co-funding by the European Union (50% versus 21%). Moreover, respondents who declared that they or their loved ones have suffered from a chronic or life-threatening disease – population categories that are particularly interested in medical and health research – are more likely to have heard of European collaborative projects (59%) than those who have not been confronted with such a situation (46%). They are also more likely to be aware that the EU funds such projects (49% versus 40%). Analysis of the results by country The differences between the countries studied confirm the above analysis: citizens in the old Member States are more aware of collaborative research projects, especially in France (72%), Sweden (72%), Denmark (70%) and the Netherlands (68%) – countries where citizens are particularly interested in health research and science and technology. Socio-demographic analysis The differences between socio-demographic categories are similar to those noted for the question which examined the level of interest in science or biological or medical research. The level of awareness of European collaborative projects and the co-funding by the EU of such projects increases significantly with the respondent’s level of education: 68% of respondents having finished their studies at the age of 20 and over have heard of collaborative projects (compared with 39% of respondents who left school at the age of 15 or before) and 57% of them have heard of European co-funding for such projects (compared with 34% of those who ended their education at an early age). Logically, given the influence of the respondent’s level of education on their degree of awareness, managers are among the respondents who are the most aware of the existence of such projects (69%) and their co-funding (60%), while relatively fewer manual workers have heard of them (49% and 41% respectively). Moreover, irrespective of the level of education, men are more likely to have heard of these projects (55%) and their co-funding (47%) than women (50% and 42% respectively). Finally, the level of awareness increases slightly with the respondent’ age, but there is no significant difference between respondents living in rural areas and those living in large towns.
Special EUROBAROMETER 265 “Medical and health research”
23
3. ACCESS TO INFORMATION ON RESEARCH
In this chapter we will begin by describing three sub-groups of respondents which are defined according to their level of awareness of EU-funded research projects and their interest in the field of science and health research. Analysing these groups allows us to better explore the link between Europeans’ awareness of biological and medical research projects and European co-funding, their interest in this particular field and, last but not least, their use of information sources. For example, we will try to understand why some Europeans who are interested in medical and health research and science and technology are unaware of research projects funded by the EU. We will also verify the assumption that the use of certain information sources makes citizens being better informed about European collaborative projects and the EU co-funding of projects. In addition, we will describe the information sources on biological and medical research which inspire the most confidence among Europeans and analyse whether Europeans use these “reliable” sources more frequently when searching for information on medical and health research. Three different groups of Europeans The population of the survey has been divided into three groups. Each group was asked three questions which were slightly modified from one group to the next:
Group A is composed of respondents who have heard of EU-funded biological and medical research projects17.
Group B comprises respondents who have not heard of such co-funded
research projects but who are interested in science or medical research18.
Finally, group C is composed of respondents who have not heard of these EU co-funded research projects and who are not interested in science or medical research19.
17 QC4a Among the following, what were your main sources of this information? (MAX. 4 ANSWERS) [IF 'AWARE OF PROJECTS FUNDED BY THE EU'] 18 QC4b Among the following, what are your main sources of information on science, or medical and health research? (MAX. 4 ANSWERS) [IF 'NOT AWARE OF PROJECTS FUNDED BY THE EU BUT INTERESTED IN THE FIELDS OF SCIENCE ANDOR MEDICAL RESEARCH'] 19 QC4c Among the following, what are your main sources of information on your subjects of interest? (MAX. 4 ANSWERS) [IF 'NOT AWARE OF THE PROJECTS FUNDED BY THE EU AND NOT INTERESTED IN THE FIELD OF SCIENCE AND MEDICAL RESEARCH']
Special EUROBAROMETER 265 “Medical and health research”
24
Analysing these groups separately provides us with more in-depth information about the factors influencing European citizens’ awareness of EU co-funded projects and their interest in this field. More precisely this analysis throws up three specific sets of results:
For group A the emphasis is on exploring how and through which information channels citizens come to know about collaborative biological and medical research projects funded by the European Union.
The focus of analysis in group B is on understanding better why citizens who
have an interest in the field of medical research and science do not know about these projects.
For respondents belonging to group C, the question remains why they are not
interested in science or medical and health research Before describing the characteristics of these groups in more detail, it should be mentioned that group C has considerably less members than the other groups. Group C consists of only 16% of respondents whereas 39% fall under group B and 45% under group A20. For this reason less emphasis should be placed on the analysis of group C. Socio-demographic characteristics The three groups differ socio-demographically. Compared with the other groups, group A, (respondents who have heard of EU co-funding for biological and medical research projects), contains more males, more people who finished education at age 20 or beyond and more people from higher socio-economic groupings. Respondents in this group have also been more frequently exposed to a chronic or life-threatening disease. Group B, (respondents who have not heard of European co-funding for biological and medical research projects but who are interested in research or science and technology), consists of more females, older and less educated people and slightly more people from lower socio-economic groupings. Respondents in group B also have slightly less personal experience of serious illnesses than those in group A. Group C, (respondents who have not heard of European co-funding for these research projects and who are not interested in research or science and technology), has even more women and people from lower socio-economic groupings. Respondents in group C have less personal experience of serious illnesses than those in the other two groups. There are no significant differences between the groups in terms of respondents living in rural areas and those living in large towns.
20 Figures based on un-weighted total of EU25 and AC. Group A: 11.872, group B: 10.399 and group C: 4.371
Special EUROBAROMETER 265 “Medical and health research”
25
EU25 Group A Group B Group C
Sex
Male 48% 51% 47% 44%
Female 52% 49% 53% 56%
Age
15-24 15% 15% 15% 17%
25-39 26% 27% 25% 27%
40-54 26% 28% 24% 22%
55+ 33% 30% 35% 34%
Education (End of)
15 24% 18% 26% 34%
16-19 41% 39% 43% 41%
20+ 23% 30% 20% 12%
Still studying 10% 11% 9% 10%
Respondent's occupation
Self-employed 8% 9% 9% 9%
Managers 10% 14% 8% 5%
Other white collars 12% 13% 11% 12%
Manual workers 20% 19% 20% 24%
House persons 9% 7% 10% 11%
Unemployed 6% 6% 6% 7%
Retired 24% 22% 26% 25%
Students 10% 11% 9% 10%
Place of living
Rural village 33% 33% 33% 33%
Small / middle size town 42% 43% 40% 45%
Large town 25% 24% 26% 22%
Chronic or life-threatening disease
Have (had) 50% 56% 50% 36%
Have not (had) 48% 43% 48% 61%
Special EUROBAROMETER 265 “Medical and health research”
26
QC3a Could you please tell me the most common way you heard of these European Union funded projects in the field of biological
and medical research? EU25
DK, 4%None
(SPONTANEOUS), 9%
Others (SPONTANEOUS),
11%
You were given this information
explicitly, 20%
You came across this information when searching
for information on sciences,
research or medicine,
25%
You deduced this yourself from
other information you received ,
31%
P opulation: Respondents who are aware of projects funded by the EU
3.1. INFORMATION ON EUROPEAN CO-FUNDING
- The importance of the active use of sources of information - Questionnaire source: QC3 Group A Respondents who are aware that the European Union funds biological and medical research projects learnt of such funding via an “active” approach21: they either deduced the existence of these projects from other information (31%), or came across the information when searching for general information on science, research or medicine (25%). Only one respondent in five (20%) learnt about these EU co-funded research projects through information communicated explicitly. Analysis of the results by country Explicit information on EU co-funded projects was mentioned above all by citizens in France (35%), Sweden (32%), Hungary (32%), Denmark (31%) and Spain (31%), while that source of information was mentioned far less frequently by citizens in Slovenia (7%), Austria (7%), Germany (6%), Cyprus (6%) and Bulgaria (3%). Moreover, more respondents learnt about the existence of European co-funding for collaborative research projects when searching for information on science, research or medicine in Slovakia (35%), Germany (34%) and Poland (31%). 21 QC3a Could you please tell me the most common way you heard of these European Union funded projects in the field of biological and medical research? [IF 'AWARE OF PROJECTS FUNDED BY THE EU']
Special EUROBAROMETER 265 “Medical and health research”
27
QC3b ...what is, among the following, the main reason why you haven’t heard of any EU-funded projects in these fields?
EU25
You did not come across this information
through your usual sources of information on
science or medicine,
37%You are
interested in science or
medicine, but not in the details,
36%
You are not interested in
European matters,
13%
Others (SPONTANEOUS,
1%
None (SPONTANEOUS,
7% DK, 5%
Population: Respondents who are not aware of projects funded by the EU but are interested in the fields of science or medical research
Group B An analysis of what is preventing greater awareness of EU-funded research projects reveals that some information sources do not provide adequate information. The fact that respondents’ interest in science or medical research is sometimes quite general also explains the lack of awareness of EU funded projects22. When Europeans interested in research or science were asked why they had not heard of EU-funded collaborative research projects, they emphasised either the inefficiency of their usual sources of information (37%), or their lack of a profound interest in science and medicine (36%), more than a lack of interest in European matters (13%).
Analysis of the results by country More citizens in the United Kingdom (53%), Greece (52%) and Slovakia (52%) did not find information on the existence of projects funded by the EU in their usual sources of information. The lack of a detailed interest in science or medicine was mainly mentioned by citizens in Luxembourg (60%), Malta (53%), Hungary (51%) and Bulgaria (50%).
22 QC3b Although you are interested in science and\or medical and health research, what is, among the following, the main reason why you haven’t heard of any EU-funded projects in these fields? [IF 'NOT AWARE OF PROJECTS FUNDED BY THE EU BUT INTERESTED IN THE FIELDS OF SCIENCE ANDOR MEDICAL RESEARCH']
Special EUROBAROMETER 265 “Medical and health research”
28
Group C Finally, for group C we noted that it is not because of a lack of confidence in the sources of information that certain European citizens are not interested in science or biological and medical research23: only 8% of them mentioned this reason, while 55% explained simply that they are not interested in science in general. Furthermore, respondents of group C confirm that their health influences their interest in medical and health research- 19% declared that they did not feel concerned as they were in good health. To conclude, sources of information logically seem to play an important role in explaining why respondents are aware or unaware of EU-funded research projects. Thus, it is interesting to focus more precisely on how people use information sources.
3.2. USE OF SOURCES OF INFORMATION
- The use of sources of information varies according to the knowledge of European co-funding for collaborative research projects and the interest in
science and medical and biological research - Questionnaire source: QC4 Europeans rely mainly on two media sources to obtain information on biological and medical research, or indeed on other topics that interest them. Not surprisingly, the vast majority of Europeans mentioned television among their main sources of information (70% of Europeans who are aware of the existence of EU-funded collaborative projects and 70% of those who have not heard of them but who are interested in research or science) and a large number of them also consult newspapers (43% and 39% respectively). Moreover, doctors and medical staff are relatively rarely mentioned as the main source of information (by 18% of respondents who have heard of EU-funded collaborative research projects and 24% of those who have not heard of such projects but who are interested in research or science).
23 QC3c Could you please tell me what is, among the following, the main reason why you are not interested in science and in medical or health research? [IF 'NOT AWARE OF THE PROJECTS FUNDED BY THE EU AND NOT INTERESTED IN THE FIELD OF SCIENCE AND MEDICAL RESEARCH']
Special EUROBAROMETER 265 “Medical and health research”
29
Main sources of information (MAX. 4 ANSWERS)
EU25
70%
43%
24%
23%
23%
20%
18%
70%
21%
24%
29%
24%21%
39%
16%
22%
19%
66%
22%
8%
14%
14%
11%
31%
Television
Newspapers
Radio
Specialized magazines, on your subjects ofinterest (including science or health magazines)
General magazines, such as news magazines,TV magazines, etc.
The Internet
Friends or members of your family
Medical doctors or staff
Is aware of projects funded by the EU
Is not aware of projects funded by the EU but is interested in the fields of science and technologyor medical and health research
Is not aware of projects funded by the EU and is neither interested in the field of science andtechnology nor in the field of medical and health research
The above chart shows the differences in use of the sources of information by the three groups of respondents and reveals that there is a link between the use of certain sources of information and awareness of EU co-funding for biological and medical research projects. Group A Europeans who have heard of such co-funding are more likely to consult specialised magazines (24%, + 8 points compared with “interested” respondents but who have not heard of EU co-funding of these projects), newspapers (43%, + 4 points) and the Internet (23%, + 4 points). However, they are less likely to seek information from doctors and medical staff (18% versus 24% of those who are interested in the topic but have not heard of European co-funding for collaborative projects).
Special EUROBAROMETER 265 “Medical and health research”
30
Group B The use of certain sources of information is also linked to the interest of citizens in science and technology or biological and medical research. Newspapers are considered as the main source of information by 39% of “interested” Europeans (a difference of +8 points compared with Europeans who are not interested in these topics), while specialised magazines were mentioned by 16% of those respondents (a difference of +8 points) and the Internet by 19% (a difference of +5 points). It is worth noting that while 70% of respondents in group B watch television for information on science or medical and health research, they do not come across any information regarding EU funded research projects. Group C For those who have not heard of EU-funded projects and who are not interested in either science and technology or biological and medical research, the question concerned the main sources of information on topics which interest them in general. The study reveals that television (66%) and newspapers (31%) are the two main sources of information of that target group, ahead of friends or family members (29%), mentioned more frequently by this target group than by the first two groups of respondents (20% among respondents who have heard of co-funding and 21% among those who have not heard of such funding but who are interested in science or biological and medical research), which seems logical given that the question concerned information in general. Finally we can conclude that even though the different groups generally seem to use similar sources of information, respondents who are aware of existing EU-funded research projects are more likely to consult newspapers, specialised magazines and, to a certain extent, the internet. These information sources therefore seem to be effective when it comes to promoting such projects. Despite the fact that a large share of respondents who are interested in health related issues have not come across any information regarding existing EU-funded research projects on the television (group B), it should be emphasised that television still remains the most important channel for information. Television is the most widely used medium both by respondents who are aware of EU-funded projects and those who are unaware of the projects. Moreover, it should also be noted that the internet may gain in importance as an information source on EU-funded research projects as young Europeans are much more likely than older age groups to find information on the internet24. In the following chapter we will focus on the level of trust that respondents generally have in different sources of information as this may increase our understanding of why certain respondents are more aware of EU-funded research projects than others.
24 For group A: 35% for age group 15-24 compared with 11% for 55+. For group B: 38% (15-24) and 7% (55+)
Special EUROBAROMETER 265 “Medical and health research”
31
3.3. RELIABLE SOURCES OF INFORMATION
- Considerable trust in doctors, medical staff and researchers - Questionnaire source: QC6 Europeans trust the different persons or organisations when it comes to information on biological and medical research25. A majority of them trust doctors and medical staff (53%), even if they are not directly involved in research, although they draw on the results of research in their work. Citizens are also likely (47%) to put their trust in researchers working at a university or government laboratory as a source of information on biological and medical research. One in four Europeans trusts the international institutions, including the EU as a source of information on biological and medical research, and almost one in five believes that non-governmental organisations and specialised associations are a reliable source of information. For these technical questions, European citizens have far more confidence in specialised journalists, scientific or health magazines (31%) than in television journalists (19%).
25 QC6 Which four of the following categories of people and organizations would you trust more when it comes to information about biological and medical research? (MAX. 4 ANSWERS)
Special EUROBAROMETER 265 “Medical and health research”
32
QC6 Which four of the following categories of people and organizations would you trust more when it comes to information
about biological and medical research? (MAX. 4 ANSWERS)EU25
53%
47%
31%
25%
19%
19%
13%
11%
10%
10%
5%
Medical doctors or staff
Researchers working at a university orgovernment laboratory
Specialized journalists writing in science orhealth magazines
International institutions (EU, UN and its health-dedicated bodies, etc.)
Non Governmental Organisations (NGO), orassociations…
TV journalists
Colleagues, friends and members of your family
Other journalists (newspapers, radio, magazine)
Teachers
Government (regional, national)
Museums, exhibitions or festivals (includingscience exhibitions)
The confidence according to the respondent's interest in science or medical research
55%
52%
27%
20%
19%
13%
11%
10%
11%
6%
43%
14%
9%
9%
8%
3%
34%
21%
14%
18%
30%
19%
Medical doctors or staff
Researchers working at a university orgovernment laboratory
Specialized journalists writing in science orhealth magazines
International institutions (EU, UN and its health-dedicated bodies, etc.)
Non Governmental Organisations (NGO), orassociations…
TV journalists
Colleagues, friends and members of yourfamily
Other journalists (newspapers, radio,magazine)
Teachers
Government (regional, national)
Museums, exhibitions or festivals (includingscience exhibitions)
Respondants interested in the field of science and technology or medical and healthresearch
Respondents neither interested in the field of science and technology nor in the field ofmedical and health research
Special EUROBAROMETER 265 “Medical and health research”
33
Europeans who are interested in sciences and technology or biological and medical research are more likely than others to trust doctors (53% versus 43% of those who are not interested in either science and technology or biological and medical research) and above all researchers (52% versus 32%). Analysis of the results by country Some national differences noted perhaps reflect successful communication between certain categories of people or organisations and the public in certain countries, but are also probably linked to the different socio-demographic profiles of the countries. Citizens in the old Member States have more confidence than those in the new Member States in doctors and medical staff. Malta is the exception (73%). Otherwise citizens in Greece (71%) and Belgium (68%) have the most confidence in this category of people as a reliable source of information on research. Moreover, citizens in Lithuania (40%), Latvia (39%) and Poland (39%) tend to have far less confidence in them. Researchers were mentioned above all by citizens in Sweden (77%), Denmark (73%) and the Netherlands (69%), while citizens in Portugal (29%) and Spain (27%) seem to have less confidence in them. Socio-demographic analysis Respondents who studied the longest tend to have more confidence in researchers as a source of information on biological and medical research. This source of information was mentioned by 58% of the people who studied up to the age of 20 and over, while it was mentioned by only 36% of respondents who left school at the age of 15. Moreover, people who have had a chronic or life-threatening disease or whose loved ones have suffered from such a disease (57%) mentioned above all doctors and medical staff (compared with 49% of those who have not experienced such a situation).
Special EUROBAROMETER 265 “Medical and health research”
34
- The sources of information considered to be the most reliable by
Europeans are rarely used by them - We note from the use of sources of information by the three groups that the sources in which Europeans have the most confidence, (that is to say doctors and researchers) are used less frequently than the others and symmetrically, the sources used the most by European citizens are not those in which they have the most confidence26. Moreover, the Pearson co-efficient show a significant negative correlation between confidence and the use of sources of information27. This negative correlation between trust in sources of information and their use by Europeans can be explained by the function of these sources. The main media – television and newspapers – provide the population with a wide range of information, including information on biological and medical research and are, therefore, widely used by the population. Conversely, doctors, although they are health specialists and inspire considerable confidence in citizens, are not seen as an important source of information, which is understandable given that providing information is not one of their main tasks. Even if that can explain the important difference between the confidence placed in the medical professions in the field of biological and medical research and the low score obtained by doctors as a source of information on these topics, this result if fairly surprising and is worth underscoring.
26 QC6 Which four of the following categories of people and organizations would you trust more when it comes to information about biological and medical research? (MAX. 4 ANSWERS) 27 Pearson = -0.52 for respondents who have heard of EU funded collaborative research projects.
Special EUROBAROMETER 265 “Medical and health research”
35
CONCLUSION The majority of Europeans are interested in medical and health research (71%), as well as in science and technology (60%). As regards biological and medical and research, Europeans seem to be most interested in the added value that such research can contribute to their daily life. Europeans are interested above all in the results of the research (78%) ahead of the research objectives and methodology. In the case of research into a specific disease, European citizens are also most interested in new discoveries (60%), some way ahead of the risks of the disease spreading (34%) and, somewhat surprisingly, the debate on the causes of the disease and its treatment (31%) and research into ways of improving the management of health care systems (25%). Therefore the best way to increase European citizens’ interest in medical and health research would be to focus on communicating the main results obtained by researchers especially with regard to new discoveries. The study also revealed that the age and level of education of respondents and their personal experience of a chronic or life-threatening disease have a significant influence on their interest in research in general, as well as in specific aspects of research. We have noted that the respondent’s age and the fact that he or she or a loved one has suffered from a chronic or life-threatening disease are correlated. However, it is difficult to determine which of the two factors is the most discriminant. Only around a half of Europeans (52%) are aware that researchers specialized in biology or medical sciences have the possibility to work with European colleagues on collaborative research projects. 44% of European citizens have heard of EU co-funding for such projects. In this regard, the study highlighted the close link between the general interest of Europeans in the field of medical research and science and technology, and the level of awareness of both these collaborative projects and their co-funding at EU level. Fairly logically, Europeans who are interested in the fields of science and research are far more likely (58%) than the others (25%) to have heard of the existence of collaborative research projects co-funded by the European Union. Respondents who are aware that the European Union funds biological and medical research projects learned of such funding through an “active” approach. They are more likely than respondents who are unaware of those projects to consult specialised magazines, newspapers and the internet. Nevertheless, television remains the most important information channel for obtaining information on science or biological and medical research, both for those who are aware of EU-funded research projects and for those who are unaware of the projects but are generally interested in science and medical research. The growing use of the internet as a source of information, especially among young Europeans, should also be taken into account.
Special EUROBAROMETER 265 “Medical and health research”
36
Finally, Europeans trust the scientific and medical professions above all when it comes to information on science or biological and health research: doctors or medical staff enjoy the most confidence (53%), followed by researchers working in a university or in a government laboratory (47%). Almost one in three Europeans (31%) trusts specialised journalists writing in science or health magazines, followed by international organisations including the European Union (25%). Conversely, far fewer European citizens (10%) trust the government (regional or national).
ANNEXES
TECHNICAL SPECIFICATIONS
SP
EC
IAL E
UR
OB
AR
OM
ETER
N°2
65
“M
ed
ical an
d h
ealt
h r
ese
arc
h”
TEC
HN
ICA
L S
PEC
IFIC
ATIO
NS
Bet
wee
n t
he
7th o
f Ju
ne
and t
he
12
th o
f Ju
ly 2
006,
TNS O
pin
ion &
Soc
ial,
a co
nso
rtiu
m c
reat
ed b
etw
een T
aylo
r N
elso
n S
ofre
s an
d E
OS G
allu
p E
uro
pe,
ca
rrie
d o
ut
wav
e 65.4
of
the
EU
RO
BARO
METE
R,
on r
eques
t of
the
EU
RO
PEAN
CO
MM
ISSIO
N,
Direc
tora
te-G
ener
al C
omm
unic
atio
n,
“Public
Opin
ion a
nd
Med
ia M
onitor
ing”.
Th
e SPE
CIA
L EU
RO
BARO
METE
R N
°265 is
par
t of
wav
e 65.4
and c
over
s th
e pop
ula
tion
of
the
resp
ective
nat
ional
itie
s of
the
Euro
pea
n U
nio
n M
ember
Sta
tes,
res
iden
t in
eac
h o
f th
e M
ember
Sta
tes
and a
ged
15 y
ears
and o
ver.
The
SPE
CIA
L EU
RO
BARO
METE
R N
°265 h
as a
lso
bee
n c
onduct
ed in t
he
two
acce
din
g c
ountr
ies
(Bulg
aria
and R
oman
ia).
In t
hes
e co
untr
ies,
the
surv
ey c
over
s th
e nat
ional
pop
ula
tion
of
citize
ns
of t
he
resp
ective
nat
ional
itie
s an
d
the
pop
ula
tion
of
citize
ns
of a
ll th
e Euro
pea
n U
nio
n M
ember
Sta
tes
that
are
res
iden
ts in t
hos
e co
untr
ies
and h
ave
a su
ffic
ient
com
man
d o
f on
e of
the
resp
ective
nat
ional
lan
guag
e(s)
to
answ
er t
he
ques
tion
nai
re. Th
e bas
ic s
ample
des
ign a
pplie
d in a
ll st
ates
is
a m
ulti-st
age,
ran
dom
(pro
bab
ility
) on
e. I
n
each
cou
ntr
y, a
num
ber
of
sam
plin
g p
oints
was
dra
wn w
ith p
robab
ility
pro
por
tion
al t
o pop
ula
tion
siz
e (f
or a
tot
al c
over
age
of t
he
countr
y) a
nd t
o pop
ula
tion
den
sity
. In
ord
er t
o do
so,
the
sam
plin
g p
oints
wer
e dra
wn s
yste
mat
ical
ly f
rom
eac
h o
f th
e "a
dm
inis
trat
ive
regio
nal
units"
, af
ter
stra
tific
atio
n b
y in
div
idual
unit
and t
ype
of a
rea.
They
thus
repre
sent
the
whol
e te
rritor
y of
the
countr
ies
surv
eyed
acc
ordin
g t
o th
e EU
RO
STA
T N
UTS
II
(or
equiv
alen
t) a
nd a
ccor
din
g
to t
he
dis
trib
ution
of
the
resi
den
t pop
ula
tion
of
the
resp
ective
nat
ional
itie
s in
ter
ms
of m
etro
pol
itan
, urb
an a
nd r
ura
l ar
eas.
In e
ach o
f th
e se
lect
ed
sam
plin
g poi
nts
, a
star
ting ad
dre
ss w
as dra
wn,
at ra
ndom
. Fu
rther
ad
dre
sses
(e
very
N
th ad
dre
ss)
wer
e se
lect
ed by
stan
dar
d "r
ando
m ro
ute
" pro
cedure
s, f
rom
the
initia
l ad
dre
ss.
In e
ach h
ouse
hol
d,
the
resp
onden
t w
as d
raw
n,
at r
andom
(fo
llow
ing t
he
"clo
sest
birth
day
rule
").
All
inte
rvie
ws
wer
e co
nduct
ed f
ace-
to-f
ace
in p
eople
's h
omes
and i
n t
he
appro
priat
e nat
ional
lan
guag
e. A
s fa
r as
the
dat
a ca
ptu
re i
s co
nce
rned
, CAPI
(Com
pute
r Ass
iste
d P
erso
nal
In
terv
iew
) w
as u
sed in
thos
e co
untr
ies
wher
e th
is t
echniq
ue
was
ava
ilable
.
A
BB
RE
VIA
TIO
NS
C
OU
NTR
IES
IN
ST
ITU
TE
S
N°
INTE
RV
IEW
S
FIE
LD
WO
RK
D
AT
ES
P
OP
ULA
TIO
N
15
+
BE
Bel
giu
m
TN
S D
imar
so
1.0
32
14/0
6/2
006
05/0
7/2
006
8.5
98.9
82
CZ
Cze
ch R
ep.
TN
S A
isa
1.0
11
13/0
6/2
006
02/0
7/2
006
8.5
71.7
10
DK
Den
mark
TN
S G
allu
p D
K
1.0
45
12/0
6/2
006
10/0
7/2
006
4.3
80.0
63
DE
Ger
man
y TN
S I
nfr
ates
t 1.5
70
13/0
6/2
006
08/0
7/2
006
64.1
74.2
95
EE
Est
onia
Em
or
1.0
04
09/0
6/2
006
03/0
7/2
006
887.0
94
EL
Gre
ece
TN
S I
CAP
1.0
00
12/0
6/2
006
08/0
7/2
006
8.6
74.2
30
ES
Spai
n
TN
S D
emosc
opia
1.0
12
11/0
6/2
006
08/0
7/2
006
35.8
82.8
20
FR
France
TN
S S
ofr
es
1.0
09
13/0
6/2
006
10/0
7/2
006
44.0
10.6
19
IE
Irel
and
TN
S M
RBI
1.0
00
07/0
6/2
006
05/0
7/2
006
3.0
89.7
75
IT
Ital
y TN
S A
bac
us
1.0
19
09/0
6/2
006
10/0
7/2
006
49.2
08.0
00
CY
Rep
. of
Cyp
rus
Syn
ova
te
504
07/0
6/2
006
04/0
7/2
006
552.2
13
LV
Latv
ia
TN
S L
atv
ia
1.0
19
13/0
6/2
006
12/0
7/2
006
1.3
94.3
51
LT
Lith
uan
ia
TN
S G
allu
p L
ithuan
ia
1.0
04
13/0
6/2
006
04/0
7/2
006
2.8
03.6
61
LU
Luxe
mbourg
TN
S I
LReS
506
07/0
6/2
006
04/0
7/2
006
367.1
99
HU
H
ungar
y TN
S H
ungar
y 1.0
15
10/0
6/2
006
30/0
6/2
006
8.5
03.3
79
MT
Malta
MIS
CO
500
09/0
6/2
006
06/0
7/2
006
322.9
17
NL
Net
her
lands
TN
S N
IPO
1.0
19
10/0
6/2
006
04/0
7/2
006
13.2
42.3
28
AT
Aust
ria
Öst
erre
ichis
ches
Gal
lup-I
nst
itut
1.0
00
08/0
6/2
006
02/0
7/2
006
6.6
79.4
44
PL
Pola
nd
TN
S O
BO
P
1.0
00
10/0
6/2
006
04/0
7/2
006
31.6
10.4
37
PT
Port
ugal
TN
S E
URO
TESTE
1.0
11
09/0
6/2
006
07/0
7/2
006
8.0
80.9
15
SI
Slo
venia
RM
PLU
S
1.0
27
10/0
6/2
006
10/0
7/2
006
1.6
63.8
69
SK
Slo
vaki
a TN
S A
ISA S
K
1.1
43
13/0
6/2
006
29/0
6/2
006
4.3
16.4
38
FI
Finla
nd
TN
S G
allu
p O
y 1.0
31
07/0
6/2
006
06/0
7/2
006
4.2
79.2
86
SE
Sw
eden
TN
S G
ALL
UP
1.0
02
13/0
6/2
006
10/0
7/2
006
7.3
76.6
80
UK
United
Kin
gdom
TN
S U
K
1.3
13
08/0
6/2
006
08/0
7/2
006
47.6
85.5
78
BG
Bulg
aria
TN
S B
BSS
1.0
25
07/0
6/2
006
20/0
6/2
006
6.6
95.5
12
RO
Rom
ania
TN
S C
SO
P
1.0
01
13/0
6/2
006
30/0
6/2
006
18.1
45.0
36
TO
TAL
26.8
22
07/0
6/2
006
12/0
7/2
006
391.1
96.8
31
SP
EC
IAL E
UR
OB
AR
OM
ETER
N°2
65
(2)
“Healt
h &
Rese
arc
h”
TEC
HN
ICA
L S
PEC
IFIC
ATIO
NS
Bet
wee
n t
he
17
th o
f N
ovem
ber
and t
he
19
th o
f D
ecem
ber
2006,
TNS O
pin
ion &
Soc
ial,
a co
nso
rtiu
m c
reat
ed b
etw
een T
aylo
r N
elso
n S
ofre
s an
d E
OS
Gal
lup E
uro
pe,
car
ried
out
wav
e 66.3
of
the
EU
RO
BARO
METE
R,
on r
eques
t of
the
EU
RO
PEAN
CO
MM
ISSIO
N,
Direc
tora
te G
ener
al C
omm
unic
atio
n,
“Public
Opin
ion a
nd M
edia
Mon
itor
ing”.
Th
e SPE
CIA
L EU
RO
BARO
METE
R N
°265(2
) is
par
t of
wav
e 66.3
and h
as b
een c
onduct
ed i
n t
he
two
candid
ate
countr
ies
(Cro
atia
and T
urk
ey).
The
surv
ey c
over
s th
e nat
ional
pop
ula
tion
of
citize
ns
of t
he
resp
ective
nat
ional
itie
s an
d t
he
pop
ula
tion
of
citize
ns
of a
ll th
e Euro
pea
n U
nio
n M
ember
Sta
tes
that
are
res
iden
ts i
n t
hos
e co
untr
ies
and h
ave
a su
ffic
ient
com
man
d o
f on
e of
the
resp
ective
nat
ional
lan
guag
e(s)
to
answ
er t
he
ques
tion
nai
re.
The
bas
ic s
ample
des
ign a
pplie
d i
n a
ll st
ates
is
a m
ulti-st
age,
ran
dom
(pro
bab
ility
) on
e. I
n e
ach c
ountr
y, a
num
ber
of
sam
plin
g p
oints
was
dra
wn w
ith
pro
bab
ility
pro
por
tion
al t
o pop
ula
tion
siz
e (f
or a
tot
al c
over
age
of t
he
countr
y) a
nd t
o pop
ula
tion
den
sity
. In
ord
er t
o do
so,
the
sam
plin
g p
oints
wer
e dra
wn s
yste
mat
ical
ly f
rom
eac
h o
f th
e "a
dm
inis
trat
ive
regio
nal
units"
, af
ter
stra
tific
atio
n b
y in
div
idual
unit
and t
ype
of a
rea.
They
thus
repre
sent
the
whol
e te
rritor
y of
the
countr
ies
surv
eyed
acc
ordin
g t
o th
e EU
RO
STA
T N
UTS
II
(or
equiv
alen
t) a
nd a
ccor
din
g
to t
he
dis
trib
ution
of
the
resi
den
t pop
ula
tion
of
the
resp
ective
nat
ional
itie
s in
ter
ms
of m
etro
pol
itan
, urb
an a
nd r
ura
l ar
eas.
In e
ach o
f th
e se
lect
ed
sam
plin
g poi
nts
, a
star
ting ad
dre
ss w
as dra
wn,
at ra
ndom
. Fu
rther
ad
dre
sses
(e
very
nth
ad
dre
ss)
wer
e se
lect
ed by
stan
dar
d "r
ando
m ro
ute
" pro
cedure
s, f
rom
the
initia
l ad
dre
ss.
In e
ach h
ouse
hol
d,
the
resp
onden
t w
as d
raw
n,
at r
andom
(fo
llow
ing t
he
"clo
sest
birth
day
rule
").
All
inte
rvie
ws
wer
e co
nduct
ed f
ace-
to-f
ace
in p
eople
's h
omes
and i
n t
he
appro
priat
e nat
ional
lan
guag
e. A
s fa
r as
the
dat
a ca
ptu
re i
s co
nce
rned
, CAPI
(Com
pute
r Ass
iste
d P
erso
nal
Inte
rvie
w)
was
use
d in
thos
e co
untr
ies
wher
e th
is t
echniq
ue
was
ava
ilable
.
AB
REV
IATIO
NS
PA
YS
IN
ST
ITU
TS
N
°
EN
QU
ETE
S
DA
TES
TE
RR
AIN
P
OP
ULA
TIO
N
15
+
HR
Cro
atia
Puls
1.0
00
17/1
1/2
006
15/1
2/2
006
3.7
22.8
00
TR
Turk
ey
TN
S P
IAR
1.0
05
17/1
1/2
006
12/1
2/2
006
47.5
83.8
30
TO
TAL
2.0
05
00/0
1/1
900
00/0
1/1
900
51.3
06.6
30
For
each
cou
ntr
y a
com
par
ison
bet
wee
n t
he
sam
ple
and t
he
univ
erse
was
car
ried
out.
The
Univ
erse
des
crip
tion
was
der
ived
fro
m E
uro
stat
pop
ula
tion
dat
a or
fro
m n
atio
nal
sta
tist
ics
offic
es.
For
all
countr
ies
surv
eyed
, a
nat
ional
wei
ghting p
roce
dure
, usi
ng m
argin
al a
nd i
nte
rcel
lula
r w
eighting,
was
ca
rrie
d o
ut
bas
ed o
n t
his
Univ
erse
des
crip
tion
. In
all
countr
ies,
gen
der
, ag
e, r
egio
n a
nd s
ize
of loc
ality
wer
e in
trod
uce
d in t
he
iter
atio
n p
roce
dure
. Fo
r in
tern
atio
nal
wei
ghting (
i.e.
EU
ave
rages
), T
NS O
pin
ion &
Soc
ial ap
plie
s th
e of
ficia
l pop
ula
tion
fig
ure
s as
pro
vided
by
EU
RO
STA
T or
nat
ional
sta
tist
ic
offic
es. Th
e to
tal p
opula
tion
fig
ure
s fo
r in
put
in t
his
pos
t-w
eighting p
roce
dure
are
list
ed a
bov
e.
Rea
der
s ar
e re
min
ded
that
surv
ey r
esults
are
estim
atio
ns ,
the
accu
racy
of
whic
h,
ever
ythin
g b
eing e
qual
, re
sts
upon
the
sam
ple
siz
e an
d u
pon
the
obse
rved
per
centa
ge.
W
ith s
ample
s of
abou
t 1,0
00 in
terv
iew
s, t
he
real
per
centa
ges
var
y w
ithin
the
follo
win
g c
onfid
ence
lim
its:
Obse
rved p
erc
en
tages
10%
or
90%
20%
or
80%
30%
or
70%
40%
or
60%
50%
Con
fiden
ce lim
its
± 1
.9 p
oints
±
2.5
poi
nts
±
2.7
poi
nts
±
3.0
poi
nts
±
3.1
poi
nts
QUESTIONNAIRE
AA
BB
CC
DD
EE
11
22
EB
65.3
E
PO
SE
R S
PLI
T U
NIQ
UE
ME
NT
EN
UE
25
SP
LIT
BA
LLO
T
A Bnotre
num
éro
d'ét
ude
EB
65.3
C
num
éro
de l'
inte
rvie
w
EB
65.3
D
votre
num
éro
d'ét
ude
EB
65.3
A
code
pay
s
EB
65.3
B
EB
65.3
E
AS
K S
PLI
T O
NLY
IN E
U25
SP
LIT
BA
LLO
T
A Bour s
urve
y nu
mbe
r
EB
65.3
C
Inte
rvie
w n
umbe
r
EB
65.3
D
your
sur
vey
num
ber
EB
65.3
A
coun
try c
ode
EB
65.3
B
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR1/
5707
/06/
2006
Q1
Q1
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
13,
13,
14,
14,
15,
15,
16,
16,
17,
17,
18,
18,
19,
19,
20,
20,
21,
21,
22,
22,
23,
23,
24,
24,
25,
25,
26,
26,
27,
27,
28,
28,
29,
29,
Aut
re p
ays
NS
P
EB
65.3
Q1
- TR
EN
D M
OD
IFIE
D
Slo
vaqu
ieS
lové
nie
Bul
garie
Rou
man
ie
Letto
nie
Litu
anie
Mal
teP
olog
ne
Rép
ubliq
ue d
e C
hypr
eR
épub
lique
tchè
que
Est
onie
Hon
grie
Roy
aum
e-U
ni (G
rand
e B
reta
gne,
Irla
nde
du N
ord)
Aut
riche
Suè
deFi
nlan
de
Italie
Luxe
mbo
urg
Pay
s-B
as
Por
tuga
l
Grè
ceE
spag
neFr
ance
Irlan
de
(PLU
SIE
UR
S R
EP
ON
SE
S P
OS
SIB
LES
)
Bel
giqu
eD
anem
ark
Alle
mag
ne
PO
SE
R IT
EM
26
UN
IQU
EM
EN
T E
N B
ULG
AR
IE
PO
SE
R IT
EM
27
UN
IQU
EM
EN
T E
N R
OU
MA
NIE
Que
lle e
st v
otre
nat
iona
lité
? V
euill
ez in
diqu
er le
(s) p
ays
qui s
'app
lique
(nt).
Oth
er c
ount
ries
DK
EB
65.3
Q1
- TR
EN
D M
OD
IFIE
D
Slo
vaki
aS
love
nia
Bul
garia
Rom
ania
Latv
iaLi
thua
nia
Mal
taP
olan
d
Rep
ublic
of C
ypru
sC
zech
Rep
ublic
Est
onia
Hun
gary
Uni
ted
Kin
gdom
(Gre
at B
ritai
n, N
orth
ern
Irela
nd)
Aus
tria
Sw
eden
Finl
and
Italy
Luxe
mbo
urg
Net
herla
nds
Por
tuga
l
Gre
ece
Spa
inFr
ance
Irela
nd
(MU
LTIP
LE A
NS
WE
RS
PO
SS
IBLE
)
Bel
gium
Den
mar
kG
erm
any
AS
K IT
EM
26
ON
LY IN
BU
LGA
RIA
AS
K IT
EM
27
ON
LY IN
RO
ME
NIA
Wha
t is
your
nat
iona
lity?
Ple
ase
tell
me
the
coun
try(ie
s) th
at a
pplie
s(y)
.
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR2/
5707
/06/
2006
QC
1Q
C1
11
22
33
44
55
66
77
88
99
NE
W
45
Les
célé
brité
s et
le
dive
rtiss
emen
t 1
23
45
Les
actu
alité
s eu
ropé
enne
s et
inte
rnat
iona
les
12
3
45
Le ja
rdin
age
et la
mai
son
12
34
5
La re
cher
che
dans
le
sect
eur m
édic
al e
t de
la
sant
é
12
3
45
Les
spor
ts e
t les
act
ivité
s de
pl
ein
air
12
34
5
Les
scie
nces
et t
echn
olog
ies
12
3
45
L’ar
t et l
a lit
téra
ture
12
34
5
Les
affa
ires
écon
omiq
ues
et
soci
ales
12
3
Pas
du
tout
in
tére
ssé(
e)
NS
P
La n
atur
e et
l’en
viro
nnem
ent
12
34
5
(LIR
E –
RO
TATI
ON
)Tr
ès
inté
ress
é(e
)
Plu
tôt
inté
ress
é(e
)
Plu
tôt p
as
inté
ress
é(e
)
A T
OU
S
Pou
r cha
cun
des
suje
ts s
uiva
nts,
pou
rrie
z-vo
us m
e di
re s
i vou
s êt
es tr
ès in
tére
ssé(
e), p
lutô
t in
tére
ssé(
e), p
lutô
t pas
inté
ress
é(e)
ou
pas
du to
ut in
tére
ssé(
e).
(MO
NTR
ER
CA
RTE
AV
EC
EC
HE
LLE
– U
NE
RE
PO
NS
E P
AR
LIG
NE
)
Par
lons
mai
nten
ant d
'un
autre
suj
et.
NE
W
45
Cel
ebrit
ies
and
ente
rtain
men
t1
23
45
Eur
opea
n an
d in
tern
atio
nal
new
s1
23
45
Hom
e an
d ga
rden
ing
12
34
5
Med
ical
and
hea
lth re
sear
ch1
23
45
Spo
rts a
nd o
utdo
or a
ctiv
ities
12
34
5
Sci
ence
and
tec
hnol
ogy
12
3
45
Art
and
liter
atur
e1
23
45
Eco
nom
ic a
nd s
ocia
l mat
ters
12
3
Not
at a
ll in
tere
sted
D
K
Nat
ure
and
the
envi
ronm
ent
12
34
5
(RE
AD
OU
T –
RO
TATE
)V
ery
inte
rest
edFa
irly
inte
rest
edN
ot v
ery
inte
rest
ed
AS
K A
LL
For e
ach
of th
e fo
llow
ing
topi
cs, p
leas
e te
ll m
e if
you
are
very
inte
rest
ed, f
airly
inte
rest
ed, n
ot
very
inte
rest
ed, o
r not
at a
ll in
tere
sted
.
(SH
OW
CA
RD
WIT
H S
CA
LE –
ON
E A
NS
WE
R P
ER
LIN
E)
Let's
mov
e on
to a
noth
er to
pic.
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR21
/57
07/0
6/20
06
QC
2aQ
C2a
11
22
QC
2bQ
C2b
11
22
NE
W
Et a
vez-
vous
déj
à en
tend
u qu
e l'U
nion
eur
opée
nne
subv
entio
nne
des
proj
ets
colle
ctifs
de
rech
erch
e su
r des
que
stio
ns li
ées
à la
bio
logi
e ou
aux
sci
ence
s m
édic
ales
?
Oui
Non
Oui
Non
NE
W
En
(NO
TRE
PA
YS
), il
y a
des
cher
cheu
rs s
péci
alis
és e
n bi
olog
ie o
u da
ns le
s sc
ienc
es
méd
ical
es. A
vez-
vous
déj
à en
tend
u qu
e ce
rtain
s d'
entre
eux
trav
aille
nt s
ur d
es p
roje
ts
colle
ctifs
de
rech
erch
e av
ec d
es c
ollè
gues
d'a
utre
s pa
ys e
urop
éens
, ou
qu’il
s on
t la
poss
ibili
té
de le
faire
?
NE
W
And
hav
e yo
u ev
er h
eard
of t
he E
urop
ean
Uni
on fu
ndin
g an
y co
llabo
rativ
e re
sear
ch p
roje
cts
on b
iolo
gy o
r med
ical
sci
ence
issu
es?
Yes
No
Yes
No
NE
W
In (O
UR
CO
UN
TRY
), th
ere
are
rese
arch
ers
spec
ializ
ed in
bio
logy
or t
he m
edic
al s
cien
ces.
H
ave
you
ever
hea
rd o
f any
of t
hem
wor
king
on
colla
bora
tive
rese
arch
pro
ject
s w
ith
colle
ague
s fro
m o
ther
Eur
opea
n co
untri
es, o
r hav
ing
the
poss
ibili
ty to
do
so?
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR22
/57
07/0
6/20
06
QC
3aQ
C3a
11
22
33
44
55
66
NE
W
Vou
s av
ez d
écou
vert
cette
info
rmat
ion
en c
herc
hant
des
info
rmat
ions
sur
le
s sc
ienc
es, l
a re
cher
che
ou la
méd
ecin
eA
ucun
e (S
PO
NTA
NE
) A
utre
s (S
PO
NTA
NE
) N
SP
Pou
rrie
z-vo
us m
e di
re c
omm
ent,
le p
lus
souv
ent,
vous
ave
z en
tend
u pa
rler d
e ce
s pr
ojet
s su
bven
tionn
és p
ar l'
Uni
on e
urop
éenn
e da
ns le
dom
aine
de
la re
cher
che
biol
ogiq
ue e
t m
édic
ale
?
(LIR
E –
UN
E S
EU
LE R
EP
ON
SE
)
Cet
te in
form
atio
n vo
us a
été
com
mun
iqué
e ex
plic
item
ent
Vou
s l’a
vez
dédu
it su
r bas
e d’
info
rmat
ions
reçu
es
L’U
nion
eur
opée
nne
subv
entio
nne
des
grou
pes
de c
herc
heur
s de
diff
éren
ts p
ays
qui v
eule
nt
trava
iller
ens
embl
e, a
u ni
veau
eur
opée
n, s
ur d
es p
roje
ts d
e re
cher
che
visa
nt à
com
battr
e de
s m
alad
ies
grav
es, à
con
cevo
ir de
nou
veau
x tra
item
ents
ou
diag
nost
ics,
ou
à en
core
mie
ux
com
pren
dre
le fo
nctio
nnem
ent d
e no
s gè
nes
et d
e no
tre c
orps
. Dan
s le
s qu
estio
ns s
uiva
ntes
, no
us d
ésig
nero
ns c
e la
rge
dom
aine
(le
com
bat c
ontre
les
mal
adie
s gr
aves
, la
conc
eptio
n de
no
uvea
ux tr
aite
men
ts, e
tc.)
par l
e te
rme
"rec
herc
he b
iolo
giqu
e et
méd
ical
e".
PO
SE
R Q
C3a
et Q
C4a
SI "
CO
NN
AIT
DE
S P
RO
JETS
SU
BV
EN
TIO
NN
ES
PA
R L
'UE
, CO
DE
1
en Q
C2b
- LE
S A
UTR
ES
ALL
ER
EN
QC
3b
NE
W
You
cam
e ac
ross
this
info
rmat
ion
whe
n se
arch
ing
for i
nfor
mat
ion
on
scie
nces
, res
earc
h or
med
icin
eN
one
(SP
ON
TAN
EO
US
)O
ther
s (S
PO
NTA
NE
OU
S)
DK
Cou
ld y
ou p
leas
e te
ll m
e th
e m
ost c
omm
on w
ay y
ou h
eard
abo
ut th
ese
Eur
opea
n U
nion
fu
nded
pro
ject
s in
the
field
of b
iolo
gica
l and
med
ical
rese
arch
?
(RE
AD
OU
T –
ON
E A
NS
WE
R O
NLY
)
You
wer
e gi
ven
this
info
rmat
ion
expl
icitl
yY
ou d
educ
ed th
is y
ours
elf f
rom
oth
er in
form
atio
n yo
u re
ceiv
ed
The
Eur
opea
n U
nion
giv
es m
oney
to g
roup
s of
peo
ple
from
diff
eren
t cou
ntrie
s w
ho w
ant t
o w
ork
toge
ther
on
rese
arch
pro
ject
s, a
t the
Eur
opea
n le
vel,
in th
e ob
ject
ive
to c
omba
t maj
or
dise
ases
, to
desi
gn n
ew tr
eatm
ents
or d
iagn
oses
or t
o be
tter u
nder
stan
d ho
w o
ur g
enes
and
bo
dy fu
nctio
n. In
the
next
que
stio
ns, w
e w
ill re
fer t
o th
is la
rge
dom
ain
(to c
omba
t maj
or
dise
ases
, to
desi
gn n
ew tr
eatm
ents
, etc
.) as
bio
logi
cal a
nd m
edic
al re
sear
ch.
AS
K Q
C3a
ans
QC
4a IF
"AW
AR
E O
F P
RO
JEC
TS F
UN
DE
D B
Y T
HE
EU
", C
OD
E 1
in Q
C2b
- O
THE
RS
GO
TO
QC
3b
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR23
/57
07/0
6/20
06
QC
4aQ
C4a
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
13,
13,
14,
14,
Aut
res
(SP
ON
TAN
E)
NS
P
NE
W
La té
lévi
sion
La ra
dio
Les
jour
naux
(quo
tidie
ns)
Inte
rnet
Les
ense
igna
nts
Les
méd
ecin
s ou
le p
erso
nnel
méd
ical
Les
mag
azin
es s
péci
alis
és d
ans
vos
cent
res
d'in
térê
t (y
com
pris
les
mag
azin
es s
cien
tifiq
ues
ou d
e sa
nté)
Les
mag
azin
es g
énér
aux,
com
me
les
mag
azin
es d
'act
ualit
é, m
agaz
ines
TV
, et
c.
Les
mus
ées,
exp
ositi
ons
ou fe
stiv
als
(y c
ompr
is d
es e
xpos
ition
s sc
ient
ifiqu
es)
Le G
ouve
rnem
ent (
natio
nal o
u ré
gion
al)
Les
collè
gues
ou
dans
le c
adre
de
votre
trav
ail
Les
amis
ou
la fa
mill
e
Par
mi l
es p
ropo
sitio
ns s
uiva
ntes
, que
lles
ont é
té v
os p
rinci
pale
s so
urce
s po
ur c
ette
in
form
atio
n ?
(MO
NTR
ER
CA
RTE
– L
IRE
– M
AX
. 4 R
EP
ON
SE
S)
Oth
ers
(SP
ON
TAN
EO
US
)D
K
NE
W
Tele
visi
onR
adio
New
spap
ers
The
Inte
rnet
Teac
hers
Med
ical
doc
tors
or s
taff
Spe
cial
ized
mag
azin
es, o
n yo
ur s
ubje
cts
of in
tere
st (i
nclu
ding
sci
ence
or
heal
th m
agaz
ines
)G
ener
al m
agaz
ines
, suc
h as
new
s m
agaz
ines
, TV
mag
azin
es, e
tc.
Mus
eum
s, e
xhib
ition
s or
fest
ival
s (in
clud
ing
scie
nce
exhi
bitio
ns)
Gov
ernm
ent (
natio
nal o
r reg
iona
l) C
olle
ague
s or
in th
e co
ntex
t of y
our w
ork
Frie
nds
or m
embe
rs o
f you
r fam
ily
Am
ong
the
follo
win
g, w
hat w
ere
your
mai
n so
urce
s of
this
info
rmat
ion?
(SH
OW
CA
RD
– R
EA
D O
UT
– M
AX
. 4 A
NS
WE
RS
)
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR24
/57
07/0
6/20
06
QC
3bQ
C3b
11
22
33
44
55
66
NS
P
NE
W
Les
suje
ts e
urop
éens
ne
vous
inté
ress
ent p
asV
ous
n'av
ez p
as tr
ouvé
cet
te in
form
atio
n da
ns v
os s
ourc
es h
abitu
elle
s d'
info
rmat
ion
sur l
es s
cien
ces
ou la
méd
ecin
eA
ucun
e (S
PO
NTA
NE
) A
utre
s (S
PO
NTA
NE
)
Bie
n qu
e vo
us s
oyez
inté
ress
é(e)
par
les
scie
nces
et\o
u la
rech
erch
e da
ns le
sec
teur
méd
ical
ou
de
la s
anté
, que
lle e
st, p
arm
i les
pro
posi
tions
sui
vant
es, l
a pr
inci
pale
rais
on p
our l
aque
lle
vous
n'a
vez
pas
ente
ndu
parle
r des
pro
jets
sub
vent
ionn
és p
ar l'
Uni
on e
urop
éenn
e da
ns c
es
dom
aine
s ?
(LIR
E –
UN
E S
EU
LE R
EP
ON
SE
)
Vou
s êt
es in
tére
ssé(
e) p
ar la
sci
ence
ou
la m
édec
ine,
mai
s pa
s da
ns le
s dé
tails
PO
SE
R Q
C3b
et Q
C4b
SI "
NE
CO
NN
AIT
PA
S D
E P
RO
JETS
SU
BV
EN
TIO
NN
ES
PA
R L
'UE
, M
AIS
ES
T IN
TER
ES
SE
PA
R L
ES
SC
IEN
CE
S E
T\O
U L
A R
EC
HE
RC
HE
ME
DIC
ALE
", C
OD
E 2
en
QC
2b E
T C
OD
E 1
ou
2 en
QC
1_4
ou Q
C1_
6 - L
ES
AU
TRE
S A
LLE
R E
N Q
C3c
DK
NE
W
You
are
not
inte
rest
ed in
Eur
opea
n m
atte
rsY
ou d
id n
ot c
ome
acro
ss th
is in
form
atio
n th
roug
h yo
ur u
sual
sou
rces
of
info
rmat
ion
on s
cien
ce o
r med
icin
eN
one
(SP
ON
TAN
EO
US
) O
ther
s (S
PO
NTA
NE
OU
S)
Alth
ough
you
are
inte
rest
ed in
sci
ence
and
\or m
edic
al a
nd h
ealth
rese
arch
, am
ong
the
follo
win
g, w
hat i
s th
e m
ain
reas
on w
hy y
ou h
aven
’t he
ard
of a
ny E
U-fu
nded
pro
ject
s in
thes
e fie
lds?
(RE
AD
OU
T –
ON
E A
NS
WE
R)
You
are
inte
rest
ed in
sci
ence
or m
edic
ine,
but
not
in th
e de
tails
AS
K Q
C3b
and
QC
4b IF
"NO
T A
WA
RE
OF
PR
OJE
CTS
FU
ND
ED
BY
TH
E E
U, B
UT
INTE
RE
STE
D IN
TH
E F
IELD
S O
F S
CIE
NC
E A
ND
\OR
ME
DIC
AL
RE
SE
AR
CH
", C
OD
E 2
in
QC
2b A
ND
CO
DE
1 o
r 2 in
QC
1_4
or Q
C1_
6 - O
THE
RS
GO
TO
QC
3c
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR25
/57
07/0
6/20
06
QC
4bQ
C4b
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
13,
13,
14,
14,
Inte
rnet
Aut
res
(SP
ON
TAN
E)
NS
P
NE
W
Les
mag
azin
es g
énér
aux,
com
me
les
mag
azin
es d
'act
ualit
é, m
agaz
ines
TV
, et
c.La
télé
visi
onLa
radi
oLe
s jo
urna
ux (q
uotid
iens
)
Les
amis
ou
la fa
mill
eLe
s en
seig
nant
sLe
s m
édec
ins
ou le
per
sonn
el m
édic
alLe
s m
agaz
ines
spé
cial
isés
dan
s vo
s ce
ntre
s d'
inté
rêt (
y co
mpr
is le
s m
agaz
ines
sci
entif
ique
s ou
de
sant
é)
(MO
NTR
ER
CA
RTE
– L
IRE
– M
AX
. 4 R
EP
ON
SE
S)
Les
mus
ées,
exp
ositi
ons
ou fe
stiv
als
(y c
ompr
is d
es e
xpos
ition
s sc
ient
ifiqu
es)
Le G
ouve
rnem
ent (
natio
nal o
u ré
gion
al)
Les
collè
gues
ou
dans
le c
adre
de
votre
trav
ail
Par
mi l
es s
ourc
es d
’info
rmat
ion
suiv
ante
s, le
sque
lles
sont
vos
prin
cipa
les
sour
ces
pour
les
scie
nces
ou
la re
cher
che
dans
le s
ecte
ur m
édic
al o
u de
la s
anté
?
The
Inte
rnet
Oth
ers
(SP
ON
TAN
EO
US
)D
K
NE
W
Gen
eral
mag
azin
es, s
uch
as n
ews
mag
azin
es, T
V m
agaz
ines
, etc
.
Tele
visi
onR
adio
New
spap
ers
Frie
nds
or m
embe
rs o
f you
r fam
ilyTe
ache
rsM
edic
al d
octo
rs o
r sta
ffS
peci
aliz
ed m
agaz
ines
, on
your
sub
ject
s of
inte
rest
(inc
ludi
ng s
cien
ce o
r he
alth
mag
azin
es)
(SH
OW
CA
RD
– R
EA
D O
UT
– M
AX
. 4 A
NS
WE
RS
)
Mus
eum
s, e
xhib
ition
s or
fest
ival
s (in
clud
ing
scie
nce
exhi
bitio
ns)
Gov
ernm
ent (
natio
nal o
r reg
iona
l) C
olle
ague
s or
in th
e co
ntex
t of y
our w
ork
Am
ong
the
follo
win
g, w
hat a
re y
our m
ain
sour
ces
of in
form
atio
n on
sci
ence
, or m
edic
al a
nd
heal
th re
sear
ch?
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR26
/57
07/0
6/20
06
QC
3cQ
C3c
11
22
33
44
55
66
Aut
res
(SP
ON
TAN
E)
NS
P
NE
W
Vou
s n'
êtes
pas
inté
ress
é(e)
par
la s
cien
ce e
n gé
néra
lV
ous
ne v
ous
sent
ez p
as c
once
rné(
e) c
ar v
ous
êtes
en
bonn
e sa
nté
Vou
s ne
faite
s pa
s co
nfia
nce
aux
sour
ces
d'in
form
atio
n su
r ces
suj
ets
Auc
une
(SP
ON
TAN
E)
PO
SE
R Q
C3c
et Q
C4c
SI "
NE
CO
NN
AIT
PA
S L
ES
PR
OJE
TS S
UB
VE
NTI
ON
NE
S P
AR
L'U
E
ET
N'E
ST
PA
S IN
TER
ES
SE
PA
R L
ES
SC
IEN
CE
S E
T\O
U L
A R
EC
HE
RC
HE
ME
DIC
ALE
", C
OD
E 2
en
QC
2b E
T C
OD
E 3
ou
4 en
QC
1_4
et Q
C1_
6 - L
ES
AU
TRE
S A
LLE
R E
N Q
C5
Pou
rrie
z-vo
us m
e di
re q
uelle
est
, par
mi l
a lis
te s
uiva
nte,
la p
rinci
pale
rais
on d
e vo
tre m
anqu
e d'
inté
rêt p
our l
es s
cien
ces
et la
rech
erch
e da
ns le
sec
teur
méd
ical
ou
de la
san
té ?
(MO
NTR
ER
CA
RTE
– L
IRE
– U
NE
SE
ULE
RE
PO
NS
E)
Oth
ers
(SP
ON
TAN
EO
US
) D
K
NE
W
You
hav
e no
inte
rest
in s
cien
ce in
gen
eral
You
do
not f
eel c
once
rned
, as
you
are
in g
ood
heal
thY
ou d
o no
t tru
st th
e so
urce
s of
info
rmat
ion
on th
ese
subj
ects
Non
e (S
PO
NTA
NE
OU
S)
AS
K Q
C3c
and
QC
4c IF
"NO
T A
WA
RE
OF
THE
PR
OJE
CTS
FU
ND
ED
BY
TH
E E
U A
ND
NO
T IN
TER
ES
TED
IN T
HE
FIE
LD O
F S
CIE
NC
E A
ND
ME
DIC
AL
RE
SE
AR
CH
", C
OD
E 2
in Q
C2b
A
ND
CO
DE
3 o
r 4 in
QC
1_4
and
QC
1_6
- OTH
ER
S G
O T
O Q
C5
Cou
ld y
ou p
leas
e te
ll m
e, a
mon
g th
e fo
llow
ing,
wha
t is
the
mai
n re
ason
why
you
are
not
in
tere
sted
in s
cien
ce a
nd in
med
ical
or h
ealth
rese
arch
?
(SH
OW
CA
RD
– R
EA
D O
UT
– O
NE
AN
SW
ER
ON
LY)
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR27
/57
07/0
6/20
06
QC
4cQ
C4c
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
13,
13,
14,
14,
NE
W
Les
jour
naux
(quo
tidie
ns)
Inte
rnet
Aut
res
(SP
ON
TAN
E)
NS
P
Les
mag
azin
es s
péci
alis
és d
ans
vos
cent
res
d'in
térê
t (y
com
pris
les
mag
azin
es s
cien
tifiq
ues
ou d
e sa
nté)
Les
mag
azin
es g
énér
aux,
com
me
les
mag
azin
es d
'act
ualit
é, m
agaz
ines
TV
, et
c.La
télé
visi
onLa
radi
o
Les
collè
gues
ou
dans
le c
adre
de
votre
trav
ail
Les
amis
ou
la fa
mill
eLe
s en
seig
nant
sLe
s m
édec
ins
ou le
per
sonn
el m
édic
al
Par
mi l
es s
ourc
es d
’info
rmat
ion
suiv
ante
s, le
sque
lles
sont
vos
sou
rces
prin
cipa
les
pour
les
suje
ts q
ui v
ous
inté
ress
ent ?
(MO
NTR
ER
CA
RTE
– L
IRE
– M
AX
. 4 R
EP
ON
SE
S)
Les
mus
ées,
exp
ositi
ons
ou fe
stiv
als
(y c
ompr
is d
es e
xpos
ition
s sc
ient
ifiqu
es)
Le G
ouve
rnem
ent (
natio
nal o
u ré
gion
al)
NE
W
New
spap
ers
The
Inte
rnet
Oth
ers
(SP
ON
TAN
EO
US
)D
K
Spe
cial
ized
mag
azin
es, o
n yo
ur s
ubje
cts
of in
tere
st (i
nclu
ding
sci
ence
or
heal
th m
agaz
ines
)G
ener
al m
agaz
ines
, suc
h as
new
s m
agaz
ines
, TV
mag
azin
es, e
tc.
Tele
visi
onR
adio
Col
leag
ues
or in
the
cont
ext o
f you
r wor
kFr
iend
s or
mem
bers
of y
our f
amily
Teac
hers
Med
ical
doc
tors
or s
taff
Am
ong
the
follo
win
g, w
hat a
re y
our m
ain
sour
ces
of in
form
atio
n on
you
r sub
ject
s of
inte
rest
?
(SH
OW
CA
RD
– R
EA
D O
UT
– M
AX
. 4 A
NS
WE
RS
)
Mus
eum
s, e
xhib
ition
s or
fest
ival
s (in
clud
ing
scie
nce
exhi
bitio
ns)
Gov
ernm
ent (
natio
nal o
r reg
iona
l)
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR28
/57
07/0
6/20
06
QC
5Q
C5
11
22
33
45
NE
W
Com
men
t les
che
rche
urs
essa
ient
d’a
ttein
dre
ce
savo
ir (c
omm
ent l
es
rech
erch
es s
ont m
enée
s)
12
3
45
Les
lanc
emen
ts d
e pr
ojet
s et
le
s pr
inci
paux
obj
ectif
s de
la
rech
erch
e (c
e qu
e l’o
n es
père
trou
ver)
12
34
5
Les
résu
ltats
fina
ux d
e la
re
cher
che
(ce
que
l’on
sait)
12
3
(MO
NTR
ER
CA
RTE
AV
EC
EC
HE
LLE
– U
NE
RE
PO
NS
E P
AR
LIG
NE
)
(LIR
E)
Très
in
tére
ssé(
e)
Plu
tôt
inté
ress
é(e
)
Plu
tôt p
as
inté
ress
é(e
)
Pas
du
tout
in
tére
ssé(
e)
NS
P
A T
OU
S
Cer
tain
s as
pect
s de
la re
cher
che
biol
ogiq
ue e
t méd
ical
e pe
uven
t vou
s in
tére
sser
plu
s pa
rticu
lière
men
t. D
ans
quel
le m
esur
e êt
es-v
ous
inté
ress
é(e)
par
cha
cun
des
aspe
cts
suiv
ants
?
45
NE
W
How
rese
arch
ers
are
tryin
g to
get
this
kno
wle
dge
(the
way
rese
arch
is c
arrie
d ou
t)
12
3
45
The
laun
ch o
f res
earc
h pr
ojec
ts a
nd th
e m
ain
obje
ctiv
es o
f the
rese
arch
(w
hat w
e ex
pect
to k
now
)
12
34
5
The
resu
lts o
f the
rese
arch
(w
hat i
s kn
own)
12
3
(SH
OW
CA
RD
WIT
H S
CA
LE –
ON
E A
NS
WE
R P
ER
LIN
E)
(RE
AD
OU
T)V
ery
inte
rest
edFa
irly
inte
rest
edN
ot v
ery
inte
rest
edN
ot a
t all
inte
rest
ed
DK
AS
K A
LL
With
in b
iolo
gica
l and
med
ical
rese
arch
, cer
tain
asp
ects
mig
ht b
e of
mor
e in
tere
st to
you
. How
in
tere
sted
are
you
in e
ach
of th
e fo
llow
ing?
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR29
/57
07/0
6/20
06
QC
6Q
C6
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
13,
13,
14,
14,
NE
W
Les
autre
s jo
urna
liste
s (jo
urna
ux, r
adio
, mag
azin
es)
Auc
une
(SP
ON
TAN
E)
Aut
res
(SP
ON
TAN
E)
NS
P
Les
inst
itutio
ns in
tern
atio
nale
s (U
E, O
NU
et s
es o
rgan
isat
ions
sur
la s
anté
, et
c.)
Les
orga
nisa
tions
non
gou
vern
emen
tale
s (O
NG
), le
s as
soci
atio
ns, c
omm
e de
s as
soci
atio
ns d
e co
nsom
mat
eurs
, des
ass
ocia
tions
car
itativ
es o
u de
s gr
oupe
s de
pat
ient
s ou
de
pres
sion
Les
jour
nalis
tes
spéc
ialis
és é
criv
ant d
ans
des
mag
azin
es s
cien
tifiq
ues
ou
de s
anté
Les
jour
nalis
tes
de té
lévi
sion
Les
méd
ecin
s ou
le p
erso
nnel
méd
ical
Les
ense
igna
nts
Les
collè
gues
de
trava
il, a
mis
et m
embr
es d
e la
fam
ille
Le G
ouve
rnem
ent (
régi
onal
, nat
iona
l)
Que
lles
sont
, par
mi l
es s
uiva
ntes
, les
qua
tre c
atég
orie
s de
per
sonn
es e
t d'o
rgan
isat
ions
au
xque
lles
vous
acc
orde
z le
plu
s vo
tre c
onfia
nce
sur l
e pl
an d
es in
form
atio
ns s
ur la
rech
erch
e bi
olog
ique
et m
édic
ale
?
(MO
NTR
ER
CA
RTE
– L
IRE
– M
AX
. 4 R
EP
ON
SE
S)
Les
mus
ées,
exp
ositi
ons
ou fe
stiv
als
(y c
ompr
is d
es e
xpos
ition
s sc
ient
ifiqu
es)
Les
cher
cheu
rs tr
avai
llant
dan
s un
e un
iver
sité
ou
un la
bora
toire
go
uver
nem
enta
l
NE
W
Oth
er jo
urna
lists
(new
spap
ers,
radi
o, m
agaz
ine)
Non
e (S
PO
NTA
NE
OU
S)
Oth
ers
(SP
ON
TAN
EO
US
) D
K
Inte
rnat
iona
l ins
titut
ions
(EU
, UN
and
its
heal
th-d
edic
ated
bod
ies,
etc
.)
Non
Gov
ernm
enta
l Org
anis
atio
ns (N
GO
), or
ass
ocia
tions
, suc
h as
co
nsum
er a
ssoc
iatio
ns, c
harit
ies,
pat
ient
or i
nter
est g
roup
s
Spe
cial
ized
jour
nalis
ts w
ritin
g in
sci
ence
or h
ealth
mag
azin
es
TV jo
urna
lists
Med
ical
doc
tors
or s
taff
Teac
hers
Col
leag
ues,
frie
nds
and
mem
bers
of y
our f
amily
Gov
ernm
ent (
regi
onal
, nat
iona
l)
Whi
ch fo
ur o
f the
follo
win
g ca
tego
ries
of p
eopl
e an
d or
gani
zatio
ns w
ould
you
trus
t mos
t whe
n it
com
es to
info
rmat
ion
abou
t bio
logi
cal a
nd m
edic
al re
sear
ch?
(SH
OW
CA
RD
– R
EA
D O
UT
– M
AX
. 4 A
NS
WE
RS
)
Mus
eum
s, e
xhib
ition
s or
fest
ival
s (in
clud
ing
scie
nce
exhi
bitio
ns)
Res
earc
hers
wor
king
at a
uni
vers
ity o
r gov
ernm
ent l
abor
ator
y
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR30
/57
07/0
6/20
06
QC
7Q
C7
1,1,
2,2,
3,3,
4,4,
5,5,
6,6,
7,7,
8,8,
9,9,
10,
10,
11,
11,
12,
12,
QC
8Q
C8
11
22
33
Oui
Non
NS
P\ R
efus
(SP
ON
TAN
E)
NE
W
NE
W
Ave
z-vo
us é
té a
ttein
t(e),
vous
-mêm
e ou
l'un
de
ceux
qui
vou
s so
nt c
hers
, par
une
mal
adie
ch
roni
que
(ast
hme,
dia
bète
, etc
.) ou
une
mal
adie
ext
rêm
emen
t gra
ve (s
ida,
can
cer,
etc.
) ?
La re
cher
che
fond
amen
tale
déb
ouch
ant s
ur d
e no
uvel
les
appr
oche
sA
ucun
e (S
PO
NTA
NE
) A
utre
s (S
PO
NTA
NE
) N
SP
Des
déb
ats
sur c
ette
mal
adie
(cau
ses,
trai
tem
ents
, etc
.)D
es é
lém
ents
vis
uels
mon
trant
la re
cher
che
sur c
ette
mal
adie
(les
ex
périe
nces
men
ées
dans
les
labo
rato
ires,
des
film
s su
r ce
que
fait
la
mal
adie
à l’
inté
rieur
du
corp
s, e
tc.)
Les
rech
erch
es s
ur l’
amél
iora
tion
de l‘
orga
nisa
tion
des
serv
ices
de
sant
é (d
ans
les
hôpi
taux
par
exe
mpl
e) p
our c
ette
mal
adie
Les
prob
lèm
es d
'éth
ique
liés
à c
ette
rech
erch
e
La v
ie a
u qu
otid
ien
des
cher
cheu
rs tr
avai
llant
sur
ce
proj
et
Les
déci
sion
s du
Gou
vern
emen
t sur
cet
te re
cher
che
Les
nouv
elle
s dé
couv
erte
sLe
trav
ail d
es c
herc
heur
s su
r les
risq
ues
de p
ropa
gatio
n de
cet
te m
alad
ie
Imag
inez
qu’
une
rech
erch
e es
t men
ée s
ur u
ne m
alad
ie im
porta
nte.
Que
ls e
n se
raie
nt le
s as
pect
s qu
i vou
s in
tére
sser
aien
t le
plus
?
(MO
NTR
ER
CA
RTE
– L
IRE
– M
AX
. 3 R
EP
ON
SE
S)
Yes
No
DK
\ Ref
usal
(SP
ON
TAN
EO
US
)
NE
W
NE
W
Do
you
or a
ny o
f you
r lov
ed o
nes,
hav
e or
hav
e ha
d a
chro
nic
dise
ase
(ast
hma,
dia
bete
s, e
tc.)
or a
life
-thre
aten
ing
dise
ase
(aid
s, c
ance
r, et
c.)?
Bas
ic re
sear
ch le
adin
g to
new
app
roac
hes
Non
e (S
PO
NTA
NE
OU
S)
Oth
ers
(SP
ON
TAN
EO
US
) D
K
Deb
ates
on
this
dis
ease
(cau
ses,
trea
tmen
ts, e
tc.)
Sho
win
g m
ater
ials
abo
ut th
e re
sear
ch o
n th
e di
seas
e (la
bora
tory
ex
perim
ents
, mov
ies
show
ing
wha
t the
dis
ease
doe
s to
the
body
, etc
.)
Res
earc
h to
impr
ove
heal
th c
are
syst
em m
anag
emen
t (e.
g. in
hos
pita
ls) f
or
this
dis
ease
E
thic
al is
sues
abo
ut th
is re
sear
ch
The
daily
life
of r
esea
rche
rs w
orki
ng o
n th
is to
pic
The
Gov
ernm
ent d
ecis
ions
abo
ut th
e re
sear
chN
ew d
isco
verie
s R
esea
rche
rs' w
ork
on th
e ris
ks o
f thi
s di
seas
e sp
read
ing
Imag
ine
that
rese
arch
is b
eing
don
e on
a m
ajor
dis
ease
. Wha
t asp
ects
of t
his
rese
arch
wou
ld
you
be th
e m
ost i
nter
este
d in
?
(SH
OW
CA
RD
– R
EA
D O
UT
– M
AX
. 3 A
NS
WE
RS
)
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR31
/57
07/0
6/20
06
D1
D1
12
34
56
78
910
12
34
56
78
910
1111
1212
D7
D7
11
22
33
44
55
66
77
88
99
1010
EB
65.3
D7
Sép
aré(
e)V
euf\V
euve
A
utre
(SP
ON
TAN
E)
Ref
us (S
PO
NTA
NE
)
Cél
ibat
aire
viv
ant a
ctue
llem
ent e
n co
uple
C
élib
atai
re n
'aya
nt ja
mai
s vé
cu e
n co
uple
Cél
ibat
aire
aya
nt d
éjà
vécu
en
coup
le d
ans
le p
assé
mai
s ac
tuel
lem
ent
seul
(e)
Div
orcé
(e)
Pou
vez-
vous
m'in
diqu
er la
lettr
e qu
i cor
resp
ond
le m
ieux
à v
otre
situ
atio
n ac
tuel
le ?
(MO
NTR
ER
CA
RTE
- LI
RE
- U
NE
SE
ULE
RE
PO
NS
E)
Mar
ié(e
)R
emar
ié(e
)
Ref
us
NS
P
EB
65.3
D1
PA
S D
E Q
UE
STI
ON
S D
2 A
D6
A p
ropo
s de
pol
itiqu
e, le
s ge
ns p
arle
nt d
e "d
roite
" et d
e "g
auch
e". V
ous-
mêm
e, v
oudr
iez-
vous
si
tuer
vot
re p
ositi
on s
ur c
ette
éch
elle
?
(MO
NTR
ER
CA
RTE
) - (E
NQ
. : N
E R
IEN
SU
GG
ER
ER
. SI L
A P
ER
SO
NN
E H
ES
ITE
, IN
SIS
TER
)
Gau
che
Dro
ite
DE
MO
GR
AP
HIQ
UE
S
EB
65.3
D7
Sep
arat
edW
idow
edO
ther
(SP
ON
TAN
EO
US
)R
efus
al (S
PO
NTA
NE
OU
S)
Unm
arrie
d, c
urre
ntly
livi
ng w
ith p
artn
erU
nmar
ried,
hav
ing
neve
r liv
ed w
ith a
par
tner
Unm
arrie
d, h
avin
g pr
evio
usly
live
d w
ith a
par
tner
, but
now
on
my
own
Div
orce
d
Cou
ld y
ou g
ive
me
the
lette
r whi
ch c
orre
spon
ds b
est t
o yo
ur o
wn
curr
ent s
ituat
ion?
(SH
OW
CA
RD
- R
EA
D O
UT
- ON
E A
NS
WE
R O
NLY
)
Mar
ried
Rem
arrie
d
Ref
usal
DK
EB
65.3
D1
NO
QU
ES
TIO
NS
D2
TO D
6
In p
oliti
cal m
atte
rs p
eopl
e ta
lk o
f "th
e le
ft" a
nd "t
he ri
ght".
How
wou
ld y
ou p
lace
you
r vie
ws
on
this
sca
le?
(SH
OW
CA
RD
) - (I
NT.
: DO
NO
T P
RO
MP
T - I
F C
ON
TAC
T H
ES
ITA
TES
, TR
Y A
GA
IN)
Left
Rig
ht
DE
MO
GR
AP
HIC
S
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR48
/57
07/0
6/20
06
D8
D8
D10
D10
11
22
D11
D11
EB
65.3
D10
Que
l est
vot
re â
ge ?
EB
65.3
D11
PA
S D
E Q
UE
STI
ON
D9
Sex
e du
répo
ndan
t.
Hom
me
Fem
me
A q
uel â
ge a
vez-
vous
arr
êté
vos
étud
es à
tem
ps c
ompl
et ?
(EN
Q. :
SI "
ETU
DIE
EN
CO
RE
", C
OD
ER
‘00’
- S
I "N
'A J
AM
AIS
FA
IT D
'ETU
DE
A T
EM
PS
C
OM
PLE
T, C
OD
ER
'98'
- S
I "N
E S
E S
OU
VIE
NT
PA
S\ N
E S
AIT
PA
S",
CO
DE
R '9
9')
EB
65.3
D8
EB
65.3
D10
How
old
are
you
?
EB
65.3
D11
NO
QU
ES
TIO
N D
9
Gen
der.
Mal
eFe
mal
e
How
old
wer
e yo
u w
hen
you
stop
ped
full-
time
educ
atio
n?
(INT.
: IF
"STI
LL S
TUD
YIN
G",
CO
DE
‘00’
- IF
"NE
VE
R H
AD
FU
LL-T
IME
ED
UC
ATI
ON
", C
OD
E
'98'
- IF
"DO
N'T
KN
OW
\ DO
N'T
RE
ME
MB
ER
, CO
DE
'98'
)
EB
65.3
D8
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR49
/57
07/0
6/20
06
D15
aD
15a
D15
bD
15b
Aut
re o
uvrie
r (no
n qu
alifi
é), p
erso
nnel
de
mai
son
1818
Con
trem
aître
, age
nt d
e m
aîtri
se16
16O
uvrie
r qua
lifié
1717
Em
ploy
é ne
trav
ailla
nt p
as d
ans
un b
urea
u m
ais
voya
gean
t (ve
ndeu
r, ch
auffe
ur, r
epré
sent
ant,
etc.
)14
14
Em
ploy
é ne
trav
ailla
nt p
as d
ans
un b
urea
u m
ais
ayan
t un
e fo
nctio
n de
ser
vice
(hôp
ital,
rest
aura
nt, p
olic
e,
pom
pier
s, e
tc.)
1515
Cad
re m
oyen
1212
Em
ploy
é tra
vaill
ant l
a pl
upar
t du
tem
ps d
ans
un b
urea
u13
13
Pro
fess
ion
libér
ale
sala
riée
(doc
teur
, avo
cat,
com
ptab
le,
arch
itect
e, e
tc.)
1010
Cad
re s
upér
ieur
\ di
rigea
nt (P
DG
\DG
, Dire
cteu
r, et
c.)
1111
Indu
strie
l, pr
oprié
taire
(en
tout
ou
en p
artie
) d'u
ne
entre
pris
e9
9
SA
LAR
IES
Pro
fess
ion
libér
ale
(avo
cat,
méd
ecin
, exp
ert c
ompt
able
, ar
chite
cte,
etc
.)7
7
Com
mer
çant
ou
prop
riéta
ire d
'un
mag
asin
, arti
san
ou
autre
trav
aille
ur in
dépe
ndan
t8
8
Agr
icul
teur
exp
loita
nt5
5P
êche
ur6
6
A la
retra
ite o
u en
con
gé d
e m
alad
ie p
rolo
ngé
44
IND
EP
EN
DA
NTS
Etu
dian
ts2
2A
u ch
ômag
e \ t
empo
raire
men
t san
s em
ploi
33
PR
OFE
SS
ION
A
CTU
ELL
EP
RO
FES
SIO
N
PR
EC
ED
EN
TEIN
AC
TIFS
En
char
ge d
es a
chat
s co
uran
ts e
t des
tâch
es m
énag
ères
ou
san
s au
cune
act
ivité
pro
fess
ionn
elle
11
PO
SE
R D
15B
SE
ULE
ME
NT
SI P
AS
D'A
CTI
VIT
E A
CTU
ELL
E, C
OD
ES
1 à
4 e
n D
15a
Que
lle e
st v
otre
pro
fess
ion
actu
elle
?
Exe
rcie
z-vo
us u
ne a
ctiv
ité p
rofe
ssio
nnel
le ré
mun
érée
aup
arav
ant ?
Laq
uelle
en
dern
ier l
ieu
?
D15
aD
15b
PA
S D
E Q
UE
STI
ON
S D
12 A
D14
Oth
er (u
nski
lled)
man
ual w
orke
r, se
rvan
t18
18
Sup
ervi
sor
1616
Ski
lled
man
ual w
orke
r17
17
Em
ploy
ed p
ositi
on, n
ot a
t a d
esk
but t
rave
lling
(sal
esm
en,
driv
er, e
tc.)
1414
Em
ploy
ed p
ositi
on, n
ot a
t a d
esk,
but
in a
ser
vice
job
(hos
pita
l, re
stau
rant
, pol
ice,
fire
man
, etc
.)15
15
Mid
dle
man
agem
ent,
othe
r man
agem
ent (
depa
rtmen
t he
ad, j
unio
r man
ager
, tea
cher
, tec
hnic
ian)
12
12
Em
ploy
ed p
ositi
on, w
orki
ng m
ainl
y at
a d
esk
1313
Em
ploy
ed p
rofe
ssio
nal (
empl
oyed
doc
tor,
law
yer,
acco
unta
nt, a
rchi
tect
)10
10
Gen
eral
man
agem
ent,
dire
ctor
or t
op m
anag
emen
t (m
anag
ing
dire
ctor
s, d
irect
or g
ener
al, o
ther
dire
ctor
)11
11
Bus
ines
s pr
oprie
tors
, ow
ner (
full
or p
artn
er) o
f a c
ompa
ny9
9
EM
PLO
YE
D
Pro
fess
iona
l (la
wye
r, m
edic
al p
ract
ition
er, a
ccou
ntan
t, ar
chite
ct, e
tc.)
77
Ow
ner o
f a s
hop,
cra
ftsm
en, o
ther
sel
f-em
ploy
ed p
erso
n8
8
Farm
er5
5Fi
sher
man
66
Ret
ired
or u
nabl
e to
wor
k th
roug
h ill
ness
44
SE
LF E
MP
LOY
ED
Stu
dent
22
Une
mpl
oyed
or t
empo
raril
y no
t wor
king
33
CU
RR
EN
T O
CC
UP
ATI
ON
LAS
T O
CC
UP
ATI
ON
NO
N-A
CTI
VE
Res
pons
ible
for o
rdin
ary
shop
ping
and
look
ing
afte
r the
ho
me,
or w
ithou
t any
cur
rent
occ
upat
ion,
not
wor
king
11
AS
K D
15b
ON
LY IF
NO
T D
OIN
G A
NY
PA
ID W
OR
K C
UR
RE
NTL
Y, C
OD
ES
1 to
4 in
D15
a
Wha
t is
your
cur
rent
occ
upat
ion?
Did
you
do
any
paid
wor
k in
the
past
? W
hat w
as y
our l
ast o
ccup
atio
n?
D15
aD
15b
NO
QU
ES
TIO
N D
12 T
O D
14
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR50
/57
07/0
6/20
06
D25
D25
11
22
33
44
D40
aD
40a
D40
bD
40b
D40
cD
40c
(EN
Q. :
LIR
E -
NO
TER
EN
CLA
IR)
EB
65.3
D40
c
Pou
vez-
vous
me
dire
com
bien
d’e
nfan
ts d
e m
oins
de
10 a
ns v
iven
t dan
s vo
tre fo
yer ?
(EN
Q. :
LIR
E -
NO
TER
EN
CLA
IR)
EB
65.3
D40
b
Pou
vez-
vous
me
dire
com
bien
d’e
nfan
ts d
e 10
à 1
4 an
s vi
vent
dan
s vo
tre fo
yer ?
PA
S D
E Q
UE
STI
ON
S D
26 A
D39
Pou
vez-
vous
me
dire
com
bien
de
pers
onne
s âg
ées
de 1
5 an
s et
plu
s vi
vent
dan
s vo
tre fo
yer,
y co
mpr
is v
ous-
mêm
e ?
(EN
Q. :
LIR
E -
NO
TER
EN
CLA
IR)
EB
65.3
D40
a
Dan
s un
e vi
lle p
etite
ou
moy
enne
Dan
s un
e gr
ande
vill
eN
SP
EB
65.3
D25
PA
S D
E Q
UE
STI
ON
S D
16 A
D24
Diri
ez-v
ous
que
vous
viv
ez …
?
(LIR
E)
Dan
s un
e co
mm
une
rura
le
N'A
JA
MA
IS E
XE
RC
E D
'AC
TIV
ITE
PR
OFE
SS
ION
NE
LLE
R
EM
UN
ER
EE
1919
EB
65.3
D15
a D
15b
(INT.
: RE
AD
OU
T - W
RIT
E D
OW
N)
EB
65.3
D40
c
Cou
ld y
ou te
ll m
e ho
w m
any
child
ren
less
than
10
year
s ol
d liv
e in
you
r hou
seho
ld?
(INT.
: RE
AD
OU
T - W
RIT
E D
OW
N)
EB
65.3
D40
b
Cou
ld y
ou te
ll m
e ho
w m
any
child
ren
aged
10
to 1
4 ye
ars
old
live
in y
our h
ouse
hold
?
NO
QU
ES
TIO
NS
D26
TO
D39
Cou
ld y
ou te
ll m
e ho
w m
any
peop
le a
ged
15 y
ears
or m
ore
live
in y
our h
ouse
hold
, you
rsel
f in
clud
ed?
(INT.
: RE
AD
OU
T - W
RIT
E D
OW
N)
EB
65.3
D40
a
Sm
all o
r mid
dle
size
d to
wn
Larg
e to
wn
DK
EB
65.3
D25
NO
QU
ES
TIO
NS
D16
TO
D24
Wou
ld y
ou s
ay y
ou li
ve in
a...
?
(RE
AD
OU
T)
Rur
al a
rea
or v
illag
e
NE
VE
R D
ID A
NY
PA
ID W
OR
K19
19
EB
65.3
D15
a D
15b
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR51
/57
07/0
6/20
06
D41
D41
11
22
33
44
55
66
D42
D42
11
22
33
44
55
66
D43
aD
43a
D43
bD
43b
Non
22
EB
65.3
D43
a D
43b
Fixe
Mob
ileO
ui1
1
EB
65.3
D42
Pos
séde
z-vo
us u
n té
léph
one
fixe
dans
vot
re fo
yer ?
Pos
séde
z-vo
us u
n té
léph
one
mob
ile\ G
SM
\ por
tabl
e pe
rson
nel ?
D43
aD
43b
Vot
re m
ère
et v
otre
pèr
e so
nt n
és d
ans
un a
utre
Eta
t mem
bre
de l’
Uni
on
euro
péen
neU
n de
vos
par
ents
est
né
en (N
OTR
E P
AY
S) e
t l’a
utre
est
né
en d
ehor
s de
l’U
nion
eur
opée
nne
Vot
re p
ère
et v
otre
mèr
e so
nt n
és e
n de
hors
de
l’Uni
on e
urop
éenn
eN
SP
\ R
efus
(SP
ON
TAN
E)
Laqu
elle
de
ces
prop
ositi
ons
corr
espo
nd à
vot
re s
ituat
ion
?
(MO
NTR
ER
CA
TRE
- LI
RE
- U
NE
SE
ULE
RE
PO
NS
E)
Vot
re m
ère
et v
otre
pèr
e so
nt n
és e
n (N
OTR
E P
AY
S)
L’un
de
vos
pare
nts
est n
é en
(NO
TRE
PA
YS
) et l
’aut
re e
st n
é da
ns u
n au
tre E
tat m
embr
e de
l’U
nion
eur
opée
nne
En
Am
ériq
ue d
u N
ord,
au
Japo
n ou
en
Océ
anie
Ref
us (S
PO
NTA
NE
)
EB
65.3
D41
NE
PA
S P
OS
ER
D42
item
5 e
n B
G e
t RO
En
(NO
TRE
PA
YS
)D
ans
un a
utre
Eta
t mem
bre
de l’
Uni
on e
urop
éenn
eE
n E
urop
e, m
ais
pas
dans
un
Eta
t mem
bre
de l’
Uni
on e
urop
éenn
eE
n A
sie,
en
Afri
que
ou e
n A
mér
ique
latin
e
Vou
s-m
ême,
ête
s-vo
us n
é(e)
?
(MO
NTR
ER
CA
RTE
- LI
RE
- U
NE
SE
ULE
RE
PO
NS
E)
No
22
EB
65.3
D43
a D
43b
Fixe
dM
obile
Yes
11
EB
65.3
D42
Do
you
own
a fix
ed te
leph
one
in y
our h
ouse
hold
?
Do
you
own
a pe
rson
al m
obile
tele
phon
e?
D43
aD
43b
You
r mot
her a
nd y
our f
athe
r wer
e bo
rn in
ano
ther
Mem
ber S
tate
of t
he
Eur
opea
n U
nion
One
of y
our p
aren
ts w
as b
orn
in (O
UR
CO
UN
TRY
) and
the
othe
r was
bor
n ou
tsid
e of
the
Eur
opea
n U
nion
You
r mot
her a
nd y
our f
athe
r wer
e bo
rn o
utsi
de th
e E
urop
ean
Uni
onD
K\R
efus
al (S
PO
NTA
NE
OU
S)
Whi
ch o
f the
se p
ropo
sals
cor
resp
onds
to y
our s
ituat
ion?
(SH
OW
CA
RD
- R
EA
D O
UT
- ON
E A
NS
WE
R O
NLY
)
You
r mot
her a
nd y
our f
athe
r wer
e bo
rn in
(OU
R C
OU
NTR
Y)
One
of y
our p
aren
ts w
as b
orn
in (O
UR
CO
UN
TRY
) and
the
othe
r was
bor
n in
ano
ther
Mem
ber S
tate
of t
he E
urop
ean
Uni
on
In N
orth
ern
Am
eric
a, in
Jap
an o
r in
Oce
ania
Ref
usal
(SP
ON
TAN
EO
US
)
EB
65.3
D41
DO
NO
T A
SK
D42
item
5 in
BG
and
RO
In (O
UR
CO
UN
TRY
)In
ano
ther
Mem
ber C
ount
ry o
f the
Eur
opea
n U
nion
In E
urop
e, b
ut n
ot in
a M
embe
r Cou
ntry
of t
he E
urop
ean
Uni
onIn
Asi
a, in
Afri
ca o
r in
Latin
Am
eric
a
You
per
sona
lly, w
ere
you
born
…?
(SH
OW
CA
RD
- R
EA
D O
UT
- ON
E A
NS
WE
R O
NLY
)
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR52
/57
07/0
6/20
06
D47
D47
11
22
33
44
55
D44
D44
11
22
33
44
55
66
77
88
99
1010
1111
1212
1313
NS
P
EB
65.3
D44
Hin
doui
ste
Ath
éist
eN
on c
roya
nt \
agno
stiq
ueA
utre
(SP
ON
TAN
E)
Juif
Mus
ulm
anS
ikh
Bou
ddhi
ste
Cat
holiq
ueO
rthod
oxe
Pro
test
ant
Aut
re c
hrét
ien
NE
W
Vou
s-m
ême,
vou
s co
nsid
érez
-vou
s co
mm
e ét
ant .
.. ?
(NE
PA
S L
IRE
- M
ON
TRE
R C
AR
TE -
LIS
TE P
RE
-CO
DE
E -
UN
E S
EU
LE R
EP
ON
SE
)
D’u
ne re
ligio
n ou
de
conv
ictio
ns d
iffér
ente
s de
s vô
tres
12
3A
ttein
t(e)s
d'u
n ha
ndic
ap
12
3H
omos
exue
l(les
)1
23
Rom
s 1
23
D’u
ne a
utre
orig
ine
ethn
ique
que
la v
ôtre
12
3
Ave
z-vo
us d
es a
mis
ou
des
rela
tions
… ?
(UN
E S
EU
LE R
EP
ON
SE
PA
R L
IGN
E)
(LIR
E)
Oui
Non
NS
P
DK
EB
65.3
D44
Hin
duA
thei
stN
on b
elie
ver\A
gnos
ticO
ther
(SP
ON
TAN
EO
US
)
Jew
ish
Mus
limS
ikh
Bud
dhis
t
Cat
holic
Orth
odox
Pro
test
ant
Oth
er C
hris
tian
NE
W
Do
you
cons
ider
you
rsel
f to
be…
?
(DO
NO
T R
EA
D -
SH
OW
CA
RD
- P
RE
CO
DE
D L
IST
- ON
E A
NS
WE
R O
NLY
)
Of a
diff
eren
t rel
igio
n or
with
diff
eren
t bel
iefs
to y
ou1
23
Dis
able
d1
23
Hom
osex
uals
12
3R
oma
12
3
Peo
ple
of w
hose
eth
nic
orig
in is
diff
eren
t fro
m y
ours
12
3
Do
you
have
frie
nds
or a
cqua
inta
nces
who
are
…?
(ON
E A
NS
WE
R P
ER
LIN
E)
(RE
AD
OU
T)Y
esN
oD
K
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR53
/57
07/0
6/20
06
D48
D48
11
22
33
NE
W
Oui
Non
Ref
us (S
PO
NTA
NE
)
Sou
ffrez
-vou
s d’
un p
robl
ème
de s
anté
chr
oniq
ue p
hysi
que
ou m
enta
l qui
vou
s gê
ne d
ans
vos
activ
ités
quot
idie
nnes
?
NE
W
Yes
No
Ref
usal
(SP
ON
TAN
EO
US
)
Do
you
suffe
r fro
m a
chr
onic
phy
sica
l or m
enta
l hea
lth p
robl
em w
hich
ham
pers
you
in y
our
daily
act
iviti
es?
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR54
/57
07/0
6/20
06
P1
P1
P2
P2
P3
P3
P4
P4
11
22
33
44
P5
P5
11
22
33
44
Bon
neM
oyen
neM
édio
cre
EB
65.3
P5
Cin
q et
plu
s
EB
65.3
P4
Coo
péra
tion
du ré
pond
ant
Exc
elle
nte
Nom
bre
de p
erso
nnes
pré
sent
es p
enda
nt l'
inte
rvie
w, l
'enq
uête
ur in
clus
.
Deu
x (l'
enqu
êteu
r et l
e ré
pond
ant)
Troi
sQ
uatre
EB
65.3
P2
DU
RE
E D
E L
'INTE
RV
IEW
EN
MIN
UTE
S
MIN
UTE
S
EB
65.3
P3
EB
65.3
P1
HE
UR
E D
U D
EB
UT
DE
L'IN
TER
VIE
W
(EN
Q. :
DE
0 A
23
HE
UR
E)
HE
UR
EM
INU
TES
PR
OTO
CO
LE D
'INTE
RV
IEW
DA
TE D
E L
'INTE
RV
IEW
JOU
RM
OIS
Fair
Ave
rage
Bad
EB
65.3
P5
Five
or m
ore
EB
65.3
P4
Res
pond
ent c
oope
ratio
n
Exc
elle
nt
Num
ber o
f per
sons
pre
sent
dur
ing
the
inte
rvie
w, i
nclu
ding
inte
rvie
wer
Two
(inte
rvie
wer
and
resp
onde
nt)
Thre
eFo
ur
EB
65.3
P2
NU
MB
ER
OF
MIN
UTE
S T
HE
INTE
RV
IEW
LA
STE
D
MIN
UTE
S
EB
65.3
P3
EB
65.3
P1
TIM
E O
F TH
E B
EG
INN
ING
OF
THE
INTE
RV
IEW
(INT.
:US
E 2
4 H
OU
R C
LOC
K)
HO
UR
MIN
UTE
S
INTE
RV
IEW
PR
OTO
CO
LE
DA
TE O
F IN
TER
VIE
W
DA
YM
ON
TH
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR55
/57
07/0
6/20
06
P6
P6
P7
P7
P8
P8
P9
P9
P10
P10
P11
P11
Fact
eur d
e po
ndér
atio
n
EB
65.3
P11
N°
poin
t de
chut
e
EB
65.3
P9
N°
enqu
êteu
r
EB
65.3
P10
(CO
DE
S L
OC
AU
X)
EB
65.3
P7
Cod
e po
stal
EB
65.3
P8
Cat
égor
ie d
'hab
itat
(CO
DE
S L
OC
AU
X)
EB
65.3
P6
Rég
ion
Wei
ghtin
g fa
ctor
EB
65.3
P11
Sam
ple
poin
t num
ber
EB
65.3
P9
Inte
rvie
wer
num
ber
EB
65.3
P10
(LO
CA
L C
OD
ES
)
EB
65.3
P7
Pos
tal c
ode
EB
65.3
P8
Siz
e of
loca
lity
(LO
CA
L C
OD
ES
)
EB
65.3
P6
Reg
ion
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR56
/57
07/0
6/20
06
P13
P13
11
22
33
Lang
ue 1
Lang
ue 2
Lang
ue 3
EB
65.3
P13
PO
SE
R U
NIQ
UE
ME
NT
en
LU, B
E, E
S, F
I, E
E, L
V e
t MT
Lang
ue d
e l'in
terv
iew
Lang
uage
1La
ngua
ge 2
Lang
uage
3
EB
65.3
P13
AS
K O
NLY
in L
U, B
E, E
S, F
I, E
E, L
V a
nd M
T
Lang
uage
of i
nter
view
Que
stio
nnai
reE
B65
4CO
MM
com
plet
EN
FR57
/57
07/0
6/20
06
TABLES
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
33%
51%
13%
3%
0%
84%
16%
BE
1032
37%
52%
9%
2%
- 89%
11%
CZ
1011
23%
55%
18%
3%
0%
78%
22%
DK
1045
37%
48%
13%
1%
0%
85%
15%
D-W
1053
35%
51%
12%
2%
- 86%
14%
DE
1570
35%
51%
11%
2%
- 87%
13%
D-E
517
36%
52%
9%
3%
- 88%
12%
EE
1004
32%
56%
11%
1%
1%
88%
12%
EL
1000
80%
16%
3%
1%
- 96%
4%
ES
1012
17%
56%
22%
4%
1%
73%
26%
FR1009
45%
49%
5%
2%
0%
93%
7%
IE1000
40%
43%
10%
6%
1%
83%
16%
I T1019
21%
55%
17%
6%
1%
75%
24%
CY
504
53%
37%
9%
1%
- 90%
10%
LV1019
36%
53%
9%
2%
0%
89%
11%
LT1004
20%
52%
23%
5%
0%
72%
28%
LU506
53%
41%
4%
1%
1%
94%
5%
HU
1015
31%
53%
13%
3%
- 84%
16%
MT
500
52%
37%
9%
1%
- 90%
10%
NL
1019
32%
51%
15%
1%
0%
83%
17%
AT
1000
41%
45%
11%
3%
1%
86%
13%
PL1000
23%
55%
17%
4%
0%
78%
21%
P T1011
35%
51%
12%
2%
0%
85%
15%
SI
1027
41%
50%
8%
1%
- 91%
9%
SK
1143
45%
47%
6%
2%
0%
92%
8%
FI1031
47%
47%
5%
1%
- 95%
5%
SE
1002
43%
47%
9%
1%
0%
90%
10%
UK
1313
40%
47%
9%
4%
0%
87%
13%
BG
1025
35%
48%
9%
6%
1%
83%
16%
RO
1001
38%
38%
16%
6%
2%
76%
22%
Nat
ure
and t
he
envi
ronm
ent
QC1.1
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
19%
50%
24%
8%
0%
68%
31%
BE
1032
12%
48%
27%
12%
- 60%
40%
CZ
1011
12%
46%
31%
10%
0%
58%
41%
DK
1045
25%
52%
21%
3%
0%
76%
23%
D-W
1053
21%
48%
24%
6%
0%
69%
30%
DE
1570
23%
48%
23%
6%
0%
70%
29%
D-E
517
27%
47%
22%
4%
- 74%
26%
EE
1004
16%
50%
30%
4%
1%
66%
33%
EL
1000
66%
27%
6%
1%
- 93%
7%
ES
1012
12%
46%
30%
11%
1%
58%
41%
FR1009
18%
50%
20%
11%
0%
68%
32%
IE1000
22%
46%
21%
9%
2%
68%
29%
I T1019
16%
54%
23%
6%
1%
70%
29%
CY
504
30%
51%
15%
4%
0%
81%
19%
LV1019
18%
49%
27%
6%
0%
67%
32%
LT1004
8%
43%
35%
14%
1%
50%
49%
LU506
30%
46%
21%
4%
1%
75%
24%
HU
1015
20%
46%
26%
7%
0%
66%
33%
MT
500
29%
39%
23%
7%
2%
68%
31%
NL
1019
20%
51%
23%
5%
0%
71%
29%
AT
1000
16%
39%
34%
11%
1%
55%
45%
PL1000
15%
55%
22%
7%
1%
70%
29%
P T1011
21%
49%
24%
6%
1%
70%
29%
SI
1027
15%
52%
28%
4%
- 67%
33%
SK
1143
32%
51%
13%
3%
0%
83%
16%
FI1031
25%
55%
19%
2%
- 79%
21%
SE
1002
27%
52%
18%
3%
1%
79%
21%
UK
1313
15%
52%
25%
8%
0%
67%
33%
BG
1025
29%
46%
15%
9%
1%
75%
24%
RO
1001
27%
38%
23%
9%
2%
65%
33%
Eco
nom
ic a
nd s
oci
al m
atte
rs
QC1.2
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
16%
36%
33%
14%
0%
52%
48%
BE
1032
15%
35%
31%
19%
0%
50%
50%
CZ
1011
15%
32%
38%
15%
0%
47%
53%
DK
1045
17%
37%
34%
13%
0%
54%
46%
D-W
1053
15%
29%
39%
17%
0%
44%
55%
DE
1570
16%
31%
39%
15%
0%
46%
54%
D-E
517
16%
37%
37%
10%
- 53%
47%
EE
1004
17%
43%
35%
5%
1%
60%
40%
EL
1000
41%
32%
18%
9%
- 73%
27%
ES
1012
10%
36%
37%
15%
1%
47%
53%
FR1009
20%
39%
27%
14%
0%
59%
41%
IE1000
16%
31%
32%
18%
2%
47%
50%
I T1019
12%
41%
33%
13%
1%
53%
45%
CY
504
20%
30%
36%
14%
- 49%
51%
LV1019
17%
40%
34%
9%
0%
57%
43%
LT1004
10%
36%
39%
16%
0%
45%
54%
LU506
21%
33%
36%
10%
0%
54%
46%
HU
1015
16%
35%
36%
13%
0%
51%
49%
MT
500
24%
26%
36%
13%
1%
50%
49%
NL
1019
21%
34%
32%
13%
- 55%
45%
AT
1000
14%
28%
34%
24%
0%
42%
58%
PL1000
11%
37%
35%
17%
1%
48%
52%
P T1011
15%
33%
40%
12%
0%
47%
52%
SI
1027
13%
38%
40%
9%
0%
52%
48%
SK
1143
15%
38%
36%
11%
0%
53%
47%
FI1031
20%
39%
34%
6%
0%
59%
41%
SE
1002
19%
36%
33%
11%
0%
55%
44%
UK
1313
17%
41%
29%
13%
0%
58%
42%
BG
1025
15%
35%
26%
21%
3%
50%
47%
RO
1001
14%
28%
35%
21%
2%
42%
56%
Art
and liter
ature
QC1.3
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
19%
41%
28%
12%
0%
60%
40%
BE
1032
21%
43%
24%
12%
0%
64%
36%
CZ
1011
9%
31%
40%
20%
0%
40%
60%
DK
1045
25%
38%
28%
9%
0%
63%
37%
D-W
1053
21%
39%
29%
11%
0%
60%
40%
DE
1570
22%
39%
29%
10%
0%
61%
39%
D-E
517
25%
40%
29%
7%
- 65%
35%
EE
1004
17%
42%
32%
9%
0%
59%
41%
EL
1000
53%
29%
13%
4%
- 82%
18%
ES
1012
11%
40%
36%
13%
1%
50%
49%
FR1009
20%
46%
21%
12%
0%
66%
33%
IE1000
15%
32%
30%
21%
2%
47%
51%
I T1019
16%
46%
27%
10%
1%
62%
37%
CY
504
24%
37%
27%
12%
0%
61%
39%
LV1019
13%
40%
34%
13%
0%
53%
47%
LT1004
8%
35%
38%
19%
1%
43%
57%
LU506
26%
42%
26%
6%
0%
68%
32%
HU
1015
19%
40%
31%
10%
0%
59%
41%
MT
500
23%
27%
31%
17%
2%
50%
48%
NL
1019
23%
42%
27%
8%
- 65%
35%
AT
1000
14%
33%
37%
15%
1%
47%
53%
PL1000
11%
40%
33%
16%
1%
50%
49%
P T1011
16%
45%
28%
9%
1%
61%
38%
SI
1027
17%
44%
32%
7%
0%
61%
39%
SK
1143
14%
38%
35%
12%
1%
52%
47%
FI1031
19%
40%
35%
7%
0%
58%
41%
SE
1002
22%
44%
26%
7%
1%
66%
33%
UK
1313
22%
40%
25%
13%
0%
62%
38%
BG
1025
16%
30%
27%
22%
4%
46%
49%
RO
1001
15%
26%
33%
22%
5%
41%
55%
Sci
ence
and
tech
nolo
gy
QC1.4
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
25%
41%
23%
10%
0%
66%
34%
BE
1032
29%
40%
20%
11%
0%
69%
31%
CZ
1011
23%
37%
26%
14%
- 60%
40%
DK
1045
27%
33%
28%
11%
0%
61%
39%
D-W
1053
25%
36%
28%
11%
- 61%
39%
DE
1570
25%
37%
27%
10%
- 62%
38%
D-E
517
25%
43%
24%
9%
- 67%
33%
EE
1004
23%
43%
27%
5%
1%
67%
33%
EL
1000
45%
27%
17%
11%
0%
72%
27%
ES
1012
17%
44%
27%
12%
0%
61%
39%
FR1009
26%
45%
19%
9%
0%
72%
28%
IE1000
43%
35%
13%
7%
2%
78%
20%
I T1019
19%
45%
24%
11%
2%
63%
35%
CY
504
31%
34%
22%
14%
- 65%
35%
LV1019
24%
39%
26%
10%
0%
64%
36%
LT1004
17%
41%
26%
15%
0%
58%
41%
LU506
38%
41%
16%
5%
- 79%
21%
HU
1015
20%
33%
31%
15%
0%
53%
47%
MT
500
33%
32%
24%
12%
0%
64%
35%
NL
1019
29%
40%
24%
7%
- 68%
32%
AT
1000
30%
36%
24%
10%
1%
65%
34%
PL1000
21%
41%
26%
12%
0%
62%
37%
P T1011
27%
42%
23%
8%
1%
69%
31%
SI
1027
24%
45%
26%
5%
- 69%
31%
SK
1143
25%
43%
24%
8%
1%
68%
31%
FI1031
33%
47%
17%
3%
- 80%
20%
SE
1002
30%
37%
23%
9%
0%
67%
32%
UK
1313
31%
42%
18%
9%
0%
73%
27%
BG
1025
17%
29%
24%
26%
3%
46%
51%
RO
1001
21%
29%
27%
20%
3%
50%
47%
Sport
s an
d o
utd
oor
activi
ties
QC1.5
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
25%
46%
21%
7%
0%
71%
28%
BE
1032
32%
47%
14%
7%
- 79%
21%
CZ
1011
11%
39%
36%
13%
- 50%
50%
DK
1045
26%
41%
26%
6%
0%
68%
32%
D-W
1053
25%
44%
23%
8%
0%
68%
31%
DE
1570
25%
43%
23%
8%
0%
69%
31%
D-E
517
28%
42%
23%
7%
- 70%
30%
EE
1004
21%
44%
28%
6%
1%
65%
34%
EL
1000
73%
19%
6%
1%
- 93%
7%
ES
1012
14%
48%
29%
8%
1%
62%
37%
FR1009
37%
48%
10%
5%
0%
85%
15%
IE1000
25%
41%
22%
10%
2%
66%
32%
I T1019
19%
54%
20%
6%
1%
72%
27%
CY
504
39%
38%
16%
7%
- 77%
23%
LV1019
20%
41%
31%
8%
0%
61%
39%
LT1004
10%
37%
36%
16%
0%
47%
52%
LU506
45%
39%
14%
2%
- 84%
16%
HU
1015
19%
42%
29%
10%
0%
61%
39%
MT
500
31%
31%
23%
14%
1%
62%
37%
NL
1019
32%
45%
19%
4%
0%
77%
22%
AT
1000
25%
43%
25%
7%
0%
68%
32%
PL1000
16%
44%
26%
13%
1%
60%
39%
P T1011
25%
46%
22%
6%
0%
72%
28%
SI
1027
19%
43%
32%
6%
0%
62%
38%
SK
1143
21%
44%
26%
9%
0%
65%
35%
FI1031
26%
49%
22%
3%
0%
75%
25%
SE
1002
22%
48%
24%
6%
0%
70%
30%
UK
1313
30%
48%
16%
6%
0%
78%
22%
BG
1025
24%
38%
18%
16%
4%
62%
34%
RO
1001
19%
33%
27%
16%
3%
53%
44%
Med
ical
and h
ealth r
esea
rch
QC1.6
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
26%
40%
23%
10%
0%
66%
34%
BE
1032
31%
42%
19%
7%
0%
74%
26%
CZ
1011
31%
41%
19%
9%
0%
72%
28%
DK
1045
29%
40%
23%
8%
0%
69%
31%
D-W
1053
28%
37%
26%
9%
0%
65%
35%
DE
1570
29%
36%
25%
9%
0%
66%
34%
D-E
517
35%
33%
21%
11%
0%
68%
32%
EE
1004
27%
40%
24%
7%
1%
68%
31%
EL
1000
45%
31%
17%
7%
- 76%
24%
ES
1012
10%
39%
33%
17%
1%
49%
50%
FR1009
29%
43%
17%
10%
0%
72%
28%
IE1000
34%
37%
16%
10%
2%
72%
27%
I T1019
18%
42%
26%
13%
1%
59%
40%
CY
504
37%
26%
24%
13%
0%
64%
36%
LV1019
27%
42%
22%
8%
1%
69%
30%
LT1004
19%
44%
27%
9%
0%
63%
36%
LU506
39%
34%
17%
9%
0%
73%
26%
HU
1015
30%
41%
21%
9%
- 71%
29%
MT
500
39%
40%
14%
7%
0%
79%
21%
NL
1019
22%
41%
27%
10%
0%
63%
37%
AT
1000
34%
37%
20%
8%
0%
71%
29%
PL1000
27%
43%
22%
7%
1%
70%
29%
P T1011
19%
38%
34%
9%
1%
57%
42%
SI
1027
34%
42%
20%
5%
- 75%
25%
SK
1143
40%
39%
16%
5%
0%
79%
21%
FI1031
26%
47%
21%
7%
- 73%
27%
SE
1002
29%
43%
20%
7%
0%
72%
28%
UK
1313
28%
42%
20%
10%
0%
71%
29%
BG
1025
34%
37%
15%
10%
3%
71%
26%
RO
1001
41%
29%
17%
10%
2%
71%
27%
Hom
e an
d g
arden
ing
QC1.7
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
20%
50%
22%
7%
0%
70%
29%
BE
1032
21%
54%
18%
7%
0%
75%
25%
CZ
1011
11%
43%
36%
10%
- 54%
46%
DK
1045
29%
50%
17%
4%
0%
79%
21%
D-W
1053
25%
47%
23%
5%
0%
72%
27%
DE
1570
25%
49%
21%
5%
0%
74%
26%
D-E
517
26%
55%
16%
3%
- 81%
19%
EE
1004
15%
52%
26%
5%
1%
68%
31%
EL
1000
41%
36%
17%
6%
0%
77%
23%
ES
1012
12%
50%
27%
11%
1%
61%
38%
FR1009
20%
51%
19%
9%
0%
72%
28%
IE1000
19%
47%
23%
9%
2%
66%
32%
I T1019
15%
52%
26%
7%
1%
66%
33%
CY
504
26%
44%
20%
10%
- 70%
30%
LV1019
10%
36%
41%
13%
0%
46%
54%
LT1004
8%
47%
32%
13%
1%
55%
45%
LU506
42%
44%
11%
2%
0%
86%
13%
HU
1015
20%
49%
24%
7%
0%
69%
31%
MT
500
32%
39%
19%
9%
1%
71%
28%
NL
1019
31%
50%
16%
3%
- 81%
19%
AT
1000
22%
40%
29%
9%
0%
61%
38%
PL1000
24%
59%
13%
4%
0%
83%
17%
P T1011
21%
48%
23%
7%
1%
69%
30%
SI
1027
10%
49%
35%
7%
0%
59%
41%
SK
1143
16%
52%
25%
7%
0%
68%
31%
FI1031
24%
56%
17%
2%
- 80%
20%
SE
1002
19%
54%
21%
6%
0%
73%
27%
UK
1313
17%
50%
22%
11%
0%
67%
33%
BG
1025
21%
50%
16%
10%
3%
71%
26%
RO
1001
21%
36%
27%
13%
3%
56%
41%
Euro
pea
n a
nd inte
rnat
ional
new
s
QC1.8
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
10%
33%
36%
22%
0%
42%
57%
BE
1032
11%
40%
33%
16%
- 51%
49%
CZ
1011
10%
33%
37%
20%
- 42%
58%
DK
1045
12%
35%
38%
16%
0%
47%
53%
D-W
1053
8%
24%
40%
27%
- 32%
68%
DE
1570
8%
24%
41%
27%
- 32%
68%
D-E
517
7%
24%
43%
26%
- 31%
69%
EE
1004
10%
33%
43%
12%
1%
44%
55%
EL
1000
25%
27%
26%
21%
0%
52%
48%
ES
1012
5%
26%
35%
33%
0%
31%
68%
FR1009
5%
33%
35%
27%
0%
38%
61%
IE1000
17%
36%
26%
18%
2%
54%
44%
I T1019
10%
38%
33%
17%
1%
48%
51%
CY
504
23%
36%
27%
13%
0%
59%
41%
LV1019
10%
28%
40%
22%
0%
38%
62%
LT1004
9%
37%
37%
17%
1%
45%
54%
LU506
20%
37%
32%
11%
0%
57%
43%
HU
1015
13%
32%
39%
16%
- 45%
55%
MT
500
29%
37%
25%
9%
0%
66%
33%
NL
1019
7%
28%
45%
20%
0%
35%
65%
AT
1000
18%
38%
31%
13%
0%
56%
44%
PL1000
12%
53%
26%
9%
1%
65%
34%
P T1011
7%
29%
39%
24%
1%
36%
64%
SI
1027
9%
38%
36%
17%
0%
47%
53%
SK
1143
13%
33%
33%
21%
1%
46%
54%
FI1031
9%
33%
45%
14%
- 41%
59%
SE
1002
7%
28%
43%
22%
0%
35%
65%
UK
1313
12%
31%
35%
21%
0%
43%
56%
BG
1025
14%
36%
26%
21%
3%
50%
46%
RO
1001
17%
31%
30%
19%
3%
48%
49%
Cel
ebrities
and e
nte
rtai
nm
ent
QC1.9
For
each
of
the
follo
win
g t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LY
es
No
UE25 E
U25
24796
52%
48%
BE
1032
65%
35%
CZ
1011
55%
45%
DK
1045
70%
30%
D-W
1053
61%
39%
DE
1570
63%
37%
D-E
517
75%
25%
EE
1004
50%
50%
EL
1000
53%
47%
ES
1012
31%
69%
FR1009
72%
28%
IE1000
28%
72%
I T1019
51%
49%
CY
504
43%
57%
LV1019
36%
64%
LT1004
31%
69%
LU506
62%
38%
HU
1015
50%
50%
MT
500
37%
63%
NL
1019
68%
32%
AT
1000
39%
61%
PL1000
51%
49%
P T1011
53%
47%
SI
1027
49%
51%
SK
1143
46%
54%
FI1031
65%
35%
SE
1002
72%
28%
UK
1313
30%
70%
BG
1025
28%
72%
RO
1001
37%
63%
QC2a
In (
OU
R C
OU
NTRY),
ther
e ar
e re
sear
cher
s sp
ecia
lized
in b
iolo
gy
or
the
med
ical
sci
ence
s. H
ave
you e
ver
hea
rd o
f an
y of
them
work
ing o
n c
olla
bora
tive
res
earc
h p
roje
cts
with c
olle
agues
fro
m o
ther
Euro
pea
n c
ountr
ies,
or
hav
ing t
he
poss
ibili
ty
to d
o s
o?
TO
TA
LY
es
No
UE25 E
U25
24796
44%
56%
BE
1032
57%
43%
CZ
1011
53%
47%
DK
1045
50%
50%
D-W
1053
46%
54%
DE
1570
48%
52%
D-E
517
60%
40%
EE
1004
50%
50%
EL
1000
53%
47%
ES
1012
33%
67%
FR1009
58%
42%
IE1000
25%
75%
I T1019
48%
52%
CY
504
55%
45%
LV1019
38%
62%
LT1004
30%
70%
LU506
59%
41%
HU
1015
46%
54%
MT
500
47%
53%
NL
1019
63%
37%
AT
1000
38%
62%
PL1000
40%
60%
P T1011
56%
44%
SI
1027
50%
50%
SK
1143
45%
55%
FI1031
62%
38%
SE
1002
37%
63%
UK
1313
22%
78%
BG
1025
26%
74%
RO
1001
30%
70%
QC2b A
nd h
ave
you e
ver
hea
rd o
f th
e Euro
pea
n U
nio
n f
undin
g a
ny
colla
bora
tive
res
earc
h p
roje
cts
on b
iolo
gy
or
med
ical
sci
ence
iss
ues
?
TO
TA
LY
ou
were
giv
en
th
is
info
rmati
on
exp
lici
tly
Yo
u d
ed
uce
d t
his
yo
urs
elf
fro
m o
ther
info
rmati
on
yo
u r
ece
ived
Yo
u c
am
e a
cro
ss t
his
in
form
ati
on
wh
en
se
arc
hin
g f
or
info
rmati
on
on
sci
en
ces,
re
searc
h o
r m
ed
icin
e
No
ne (
SP
ON
TA
NEO
US
)O
thers
(S
PO
NTA
NEO
US
)D
K
UE25 E
U25
10954
20%
31%
25%
9%
11%
4%
BE
584
24%
46%
18%
7%
5%
- CZ
533
24%
37%
25%
6%
6%
2%
DK
517
31%
29%
22%
5%
9%
4%
D-W
481
6%
29%
32%
21%
9%
4%
DE
761
6%
26%
34%
20%
11%
4%
D-E
310
7%
16%
38%
17%
19%
3%
EE
497
13%
36%
29%
11%
8%
4%
EL
526
24%
48%
25%
2%
1%
- ES
336
31%
23%
15%
18%
11%
1%
FR587
35%
29%
19%
2%
11%
4%
IE247
12%
28%
28%
9%
14%
8%
I T486
14%
29%
28%
3%
20%
5%
CY
275
6%
26%
21%
17%
28%
1%
LV391
26%
32%
26%
4%
9%
2%
LT301
28%
25%
21%
14%
3%
9%
LU299
18%
44%
25%
1%
9%
3%
HU
463
32%
37%
6%
14%
6%
4%
MT
235
19%
43%
12%
6%
19%
0%
NL
638
17%
47%
19%
7%
7%
3%
AT
380
7%
31%
29%
23%
6%
4%
PL401
16%
31%
31%
9%
7%
5%
P T570
22%
31%
19%
7%
18%
3%
SI
514
7%
38%
30%
15%
7%
4%
SK
519
20%
37%
35%
1%
4%
3%
FI639
22%
36%
28%
6%
6%
2%
SE
371
32%
28%
25%
2%
10%
3%
UK
283
21%
38%
26%
6%
4%
5%
BG
263
3%
44%
22%
15%
12%
4%
RO
300
18%
39%
21%
7%
6%
8%
(IF
'AW
ARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U', C
OD
E 1
IN
QC2b)
QC3a
Could
you p
leas
e te
ll m
e th
e m
ost
com
mon w
ay y
ou h
eard
of
thes
e Euro
pea
n U
nio
n f
unded
pro
ject
s in
the
fiel
d o
f bio
logic
al a
nd m
edic
al r
esea
rch?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he
con
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
alize
d
mag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
er
sTh
e
Inte
rnet
Oth
ers
(S
PO
NTA
NE
OU
S)
DK
UE25 E
U25
10954
4%
6%
13%
20%
7%
18%
24%
23%
70%
24%
43%
23%
1%
1%
BE
584
4%
8%
13%
21%
10%
20%
19%
24%
78%
29%
49%
23%
2%
0%
CZ
533
5%
2%
8%
17%
8%
12%
22%
27%
78%
27%
49%
23%
0%
1%
DK
517
3%
7%
24%
19%
8%
17%
22%
23%
70%
33%
51%
27%
0%
1%
D-W
481
5%
5%
13%
16%
5%
21%
27%
28%
75%
28%
56%
29%
1%
1%
DE
761
5%
4%
13%
18%
5%
20%
30%
30%
75%
29%
55%
29%
1%
1%
D-E
310
4%
2%
12%
23%
2%
16%
41%
36%
75%
32%
51%
31%
1%
1%
EE
497
3%
4%
9%
16%
7%
15%
22%
22%
71%
36%
54%
31%
0%
2%
EL
526
2%
3%
9%
21%
4%
18%
20%
14%
83%
19%
36%
10%
1%
- ES
336
1%
5%
7%
15%
5%
10%
12%
9%
66%
25%
29%
17%
2%
1%
FR587
4%
7%
13%
23%
8%
24%
26%
30%
72%
31%
39%
20%
1%
1%
IE247
9%
10%
19%
29%
11%
19%
31%
22%
62%
29%
50%
23%
1%
3%
I T486
4%
7%
12%
28%
7%
16%
22%
20%
62%
8%
28%
9%
1%
- CY
275
2%
7%
10%
35%
10%
23%
12%
16%
76%
26%
47%
18%
1%
1%
LV391
5%
2%
16%
20%
7%
12%
18%
25%
79%
40%
52%
28%
- 1%
LT301
2%
4%
17%
21%
5%
12%
29%
18%
76%
35%
46%
24%
0%
4%
LU299
6%
8%
13%
29%
8%
16%
20%
27%
67%
38%
53%
29%
1%
0%
HU
463
4%
8%
11%
19%
4%
13%
15%
16%
75%
29%
43%
18%
0%
2%
MT
235
3%
7%
12%
14%
7%
14%
12%
17%
63%
34%
50%
20%
1%
0%
NL
638
5%
10%
21%
22%
6%
17%
28%
24%
61%
19%
59%
35%
1%
2%
AT
380
4%
13%
21%
29%
12%
27%
37%
23%
54%
18%
38%
19%
1%
3%
PL401
3%
3%
10%
13%
12%
16%
26%
15%
72%
31%
33%
30%
- 2%
P T570
4%
4%
9%
20%
8%
14%
18%
21%
81%
14%
34%
15%
- 2%
SI
514
2%
4%
8%
20%
8%
14%
29%
17%
71%
22%
46%
28%
1%
2%
SK
519
3%
2%
10%
25%
5%
17%
27%
42%
78%
33%
41%
30%
0%
3%
FI639
3%
10%
16%
17%
10%
20%
33%
31%
69%
23%
58%
26%
1%
- SE
371
3%
7%
21%
16%
9%
15%
32%
31%
67%
33%
59%
27%
1%
1%
UK
283
5%
7%
19%
15%
8%
16%
19%
18%
62%
20%
56%
38%
2%
1%
BG
263
4%
3%
12%
18%
6%
21%
15%
10%
83%
38%
49%
19%
1%
2%
RO
300
6%
4%
13%
19%
13%
23%
24%
28%
72%
29%
31%
15%
1%
5%
(IF
'AW
ARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U', C
OD
E 1
IN
QC2b)
QC4a
Am
ong t
he
follo
win
g,
what
wer
e yo
ur
mai
n s
ourc
es o
f th
is info
rmat
ion?
(MAX.
4 A
NSW
ERS)
TO
TA
LY
ou
are
in
tere
sted
in
sc
ien
ce o
r m
ed
icin
e,
bu
t n
ot
in t
he d
eta
ils
Yo
u a
re n
ot
inte
rest
ed
in
Eu
rop
ean
matt
ers
Yo
u d
id n
ot
com
e a
cro
ss
this
in
form
ati
on
th
rou
gh
yo
ur
usu
al so
urc
es
of
info
rmati
on
on
sci
en
ce
or
med
icin
e
No
ne (
SP
ON
TA
NEO
US
) O
thers
(S
PO
NTA
NEO
US
) D
K
UE25 E
U25
10149
36%
13%
37%
7%
1%
5%
BE
362
45%
17%
34%
3%
1%
0%
CZ
236
43%
10%
35%
7%
0%
4%
DK
388
36%
13%
43%
2%
2%
5%
D-W
422
41%
11%
35%
9%
1%
4%
DE
598
40%
10%
36%
9%
1%
4%
D-E
157
38%
6%
41%
9%
2%
3%
EE
402
31%
22%
20%
13%
3%
10%
EL
428
43%
2%
52%
2%
0%
0%
ES
404
40%
11%
17%
17%
3%
11%
FR355
43%
11%
37%
3%
2%
4%
IE496
39%
6%
31%
3%
0%
20%
I T384
34%
24%
26%
12%
1%
3%
CY
177
41%
3%
28%
10%
7%
10%
LV443
37%
15%
39%
4%
- 4%
LT391
42%
10%
27%
11%
1%
10%
LU182
60%
11%
23%
1%
2%
4%
HU
344
51%
14%
20%
10%
0%
6%
MT
168
53%
9%
29%
4%
- 4%
NL
331
34%
14%
47%
2%
1%
1%
AT
413
34%
16%
29%
13%
1%
5%
PL383
40%
10%
40%
3%
1%
5%
P T256
44%
2%
24%
12%
- 18%
SI
327
31%
20%
29%
12%
2%
4%
SK
366
33%
5%
52%
1%
0%
8%
FI312
35%
23%
29%
4%
4%
5%
SE
512
37%
5%
47%
2%
3%
6%
UK
873
23%
15%
53%
5%
- 4%
BG
473
50%
6%
23%
11%
2%
9%
RO
367
42%
10%
13%
7%
3%
25%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U B
UT I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
OR M
ED
ICAL
RESEARCH
', C
OD
E 2
IN
QC2b A
ND
CO
DE 1
OR 2
IN
QC1_4 O
R Q
C1_6)
QC3b A
lthough y
ou a
re inte
rest
ed in s
cien
ce a
nd\o
r m
edic
al a
nd h
ealth r
esea
rch,
what
is,
am
ong t
he
follo
win
g,
the
mai
n r
easo
n w
hy
you h
aven
’t h
eard
of
any
EU
-funded
pro
ject
s in
thes
e fiel
ds?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he
con
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
alize
d
mag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
er
sTh
e
Inte
rnet
Oth
ers
(S
PO
NTA
NE
OU
S)
DK
UE25 E
U25
10149
5%
7%
9%
21%
7%
24%
16%
22%
70%
21%
39%
19%
1%
4%
BE
362
3%
11%
15%
24%
11%
35%
16%
20%
68%
25%
40%
22%
- 0%
CZ
236
4%
0%
6%
30%
3%
22%
18%
29%
77%
26%
38%
17%
- 1%
DK
388
3%
7%
22%
23%
4%
22%
19%
28%
74%
38%
55%
30%
2%
1%
D-W
422
6%
4%
8%
17%
8%
24%
20%
33%
73%
20%
54%
20%
1%
2%
DE
598
6%
4%
9%
18%
8%
24%
22%
32%
73%
21%
52%
20%
1%
2%
D-E
157
7%
1%
14%
22%
6%
25%
31%
28%
75%
29%
42%
20%
1%
1%
EE
402
3%
2%
7%
15%
5%
22%
15%
20%
67%
40%
43%
21%
1%
9%
EL
428
1%
5%
5%
29%
3%
30%
16%
12%
89%
16%
23%
5%
1%
0%
ES
404
2%
5%
4%
17%
7%
22%
9%
6%
57%
18%
23%
13%
2%
10%
FR355
6%
5%
10%
29%
5%
34%
22%
28%
74%
23%
37%
18%
1%
3%
IE496
3%
5%
7%
24%
5%
19%
13%
23%
70%
37%
50%
14%
1%
12%
I T384
4%
20%
11%
20%
5%
18%
10%
19%
56%
10%
19%
7%
- 3%
CY
177
1%
- 7%
26%
9%
20%
9%
18%
82%
34%
34%
5%
- 3%
LV443
6%
1%
9%
20%
6%
12%
14%
19%
79%
36%
48%
25%
- 3%
LT391
2%
3%
3%
14%
8%
19%
21%
17%
78%
35%
50%
24%
0%
3%
LU182
2%
5%
12%
26%
7%
25%
11%
27%
79%
38%
42%
21%
2%
2%
HU
344
3%
8%
10%
18%
7%
13%
11%
14%
72%
28%
34%
15%
0%
4%
MT
168
3%
7%
8%
34%
12%
47%
11%
17%
62%
22%
24%
15%
- 3%
NL
331
6%
7%
15%
28%
6%
22%
27%
31%
72%
17%
57%
38%
1%
1%
AT
413
7%
10%
15%
28%
10%
34%
26%
25%
63%
27%
42%
10%
1%
1%
PL383
4%
4%
8%
16%
15%
22%
23%
15%
71%
26%
18%
19%
1%
4%
P T256
1%
3%
4%
14%
4%
23%
10%
17%
78%
12%
28%
8%
- 10%
SI
327
3%
2%
7%
23%
6%
23%
29%
11%
62%
21%
36%
22%
3%
5%
SK
366
3%
2%
9%
28%
10%
16%
17%
36%
74%
26%
34%
13%
1%
8%
FI312
3%
5%
8%
19%
8%
32%
33%
28%
65%
16%
45%
30%
1%
0%
SE
512
3%
2%
14%
22%
3%
20%
27%
32%
80%
36%
65%
32%
1%
2%
UK
873
7%
5%
9%
19%
8%
22%
11%
22%
74%
24%
52%
28%
1%
4%
BG
473
1%
3%
7%
21%
3%
24%
9%
11%
81%
33%
44%
11%
0%
9%
RO
367
2%
3%
8%
17%
11%
23%
15%
17%
62%
35%
22%
11%
1%
17%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U B
UT I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
OR M
ED
ICAL
RESEARCH
', C
OD
E 2
IN
QC2b A
ND
CO
DE 1
OR 2
IN
QC1_4 O
R Q
C1_6)
QC4b A
mong t
he
follo
win
g,
what
are
your
mai
n s
ourc
es o
f in
form
atio
n o
n s
cien
ce,
or
med
ical
and h
ealth r
esea
rch?
(MAX.
4 A
NSW
ERS)
TO
TA
LY
ou
have n
o in
tere
st in
sc
ien
ce in
gen
era
l
Yo
u d
o n
ot
feel
con
cern
ed
, as
yo
u a
re in
g
oo
d h
ealt
h
Yo
u d
o n
ot
tru
st t
he
sou
rces
of
info
rmati
on
o
n t
hese
su
bje
cts
No
ne (
SP
ON
TA
NEO
US
) O
thers
(S
PO
NTA
NEO
US
) D
K
UE25 E
U25
3577
55%
19%
8%
10%
3%
5%
BE
84
53%
33%
5%
4%
3%
2%
CZ
241
59%
19%
6%
9%
3%
5%
DK
138
64%
16%
4%
11%
2%
3%
D-W
147
45%
22%
15%
12%
2%
3%
DE
206
45%
21%
15%
13%
3%
3%
D-E
50
50%
10%
16%
15%
7%
2%
EE
104
41%
28%
8%
10%
7%
5%
EL
46
54%
16%
20%
5%
5%
- ES
262
58%
12%
4%
15%
5%
6%
FR67
75%
9%
10%
- 2%
4%
IE236
61%
12%
4%
4%
2%
17%
I T140
50%
19%
15%
12%
2%
3%
CY
52
50%
17%
9%
9%
4%
11%
LV185
55%
18%
7%
12%
2%
6%
LT305
37%
22%
8%
17%
5%
10%
LU25
73%
12%
11%
- 4%
- H
U205
56%
16%
8%
13%
1%
6%
MT
91
79%
10%
5%
4%
- 2%
NL
50
39%
30%
2%
5%
18%
6%
AT
201
53%
27%
8%
6%
4%
2%
PL207
52%
30%
3%
6%
2%
7%
P T183
60%
6%
4%
9%
- 21%
SI
186
55%
21%
5%
9%
5%
4%
SK
254
68%
10%
9%
2%
2%
8%
FI79
53%
30%
2%
3%
5%
6%
SE
115
68%
18%
3%
3%
3%
6%
UK
152
61%
19%
5%
11%
2%
1%
BG
245
73%
10%
4%
3%
2%
8%
RO
298
52%
10%
3%
7%
3%
25%
(IF
'NO
T A
WARE O
F TH
E P
RO
JECTS F
UN
DED
BY T
HE E
U A
ND
NO
T I
NTERESTED
IN
TH
E F
IELD
OF
SCIE
NCE A
ND
MED
ICAL
RESEARCH
', C
OD
E 2
IN
QC2b A
ND
CO
DE 3
OR 4
IN
QC1_4 A
ND
QC1_6)
QC3c
Could
you p
leas
e te
ll m
e w
hat
is,
am
ong t
he
follo
win
g,
the
mai
n r
easo
n w
hy
you a
re n
ot
inte
rest
ed in s
cien
ce a
nd in m
edic
al o
r hea
lth r
esea
rch?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he
con
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
alize
d
mag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
er
sTh
e
Inte
rnet
Oth
ers
(S
PO
NTA
NE
OU
S)
DK
UE25 E
U25
3577
4%
4%
9%
29%
5%
11%
8%
14%
66%
22%
31%
14%
1%
11%
BE
84
8%
16%
10%
36%
11%
10%
9%
18%
73%
23%
29%
21%
- 3%
CZ
241
6%
1%
15%
43%
5%
5%
11%
22%
77%
17%
39%
22%
- 1%
DK
138
10%
8%
32%
45%
10%
8%
12%
17%
76%
24%
42%
38%
2%
0%
D-W
147
3%
1%
8%
30%
6%
22%
8%
25%
63%
22%
46%
15%
1%
6%
DE
206
3%
1%
8%
30%
6%
21%
9%
24%
65%
24%
47%
15%
1%
5%
D-E
50
4%
- 7%
31%
8%
14%
9%
18%
76%
34%
58%
15%
1%
- EE
104
3%
1%
6%
25%
3%
6%
14%
15%
72%
36%
44%
32%
- 16%
EL
46
- -
7%
34%
5%
12%
11%
15%
89%
- 19%
8%
- 2%
ES
262
1%
6%
3%
21%
6%
15%
7%
4%
56%
19%
17%
9%
2%
13%
FR67
11%
- 5%
28%
10%
8%
9%
23%
64%
25%
35%
12%
- 15%
IE236
5%
3%
5%
25%
6%
7%
5%
15%
71%
39%
44%
11%
0%
17%
I T140
1%
11%
13%
36%
5%
5%
7%
15%
63%
12%
17%
8%
2%
8%
CY
52
3%
3%
12%
35%
5%
7%
2%
9%
75%
31%
24%
8%
6%
8%
LV185
2%
1%
11%
29%
4%
2%
9%
16%
75%
34%
40%
18%
- 8%
LT305
2%
4%
6%
15%
7%
10%
9%
8%
74%
33%
40%
14%
1%
10%
LU25
- -
6%
35%
6%
4%
4%
16%
81%
66%
42%
17%
- -
HU
205
0%
4%
10%
24%
2%
16%
7%
6%
50%
11%
16%
9%
2%
22%
MT
91
2%
9%
2%
24%
12%
21%
9%
11%
67%
28%
27%
9%
1%
14%
NL
50
17%
8%
16%
45%
8%
5%
30%
24%
71%
32%
44%
61%
- -
AT
201
3%
7%
21%
36%
4%
19%
11%
15%
67%
22%
45%
11%
3%
4%
PL207
5%
1%
16%
29%
6%
7%
7%
5%
75%
28%
27%
10%
- 7%
P T183
- 2%
1%
10%
3%
12%
3%
5%
62%
9%
13%
1%
- 31%
SI
186
2%
- 5%
44%
6%
7%
11%
9%
78%
30%
37%
20%
7%
5%
SK
254
2%
1%
8%
33%
7%
7%
8%
29%
80%
32%
43%
14%
- 10%
FI79
6%
7%
7%
31%
5%
22%
13%
27%
64%
23%
48%
34%
1%
5%
SE
115
6%
3%
10%
33%
5%
8%
11%
26%
76%
32%
59%
37%
2%
8%
UK
152
5%
3%
6%
29%
2%
2%
8%
18%
64%
31%
45%
23%
2%
20%
BG
245
2%
1%
5%
17%
2%
10%
3%
4%
78%
27%
27%
3%
0%
14%
RO
298
1%
1%
6%
16%
3%
7%
3%
10%
54%
29%
16%
6%
1%
26%
(IF
'NO
T A
WARE O
F TH
E P
RO
JECTS F
UN
DED
BY T
HE E
U A
ND
NO
T I
NTERESTED
IN
TH
E F
IELD
OF
SCIE
NCE A
ND
MED
ICAL
RESEARCH
', C
OD
E 2
IN
QC2b A
ND
CO
DE 3
OR 4
IN
QC1_4 A
ND
QC1_6)
QC4c
Am
ong t
he
follo
win
g,
what
are
your
mai
n s
ourc
es o
f in
form
atio
n o
n y
our
subje
cts
of
inte
rest
? (M
AX.
4 A
NSW
ERS)
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
27%
51%
15%
5%
2%
78%
20%
BE
1032
34%
55%
8%
3%
0%
90%
10%
CZ
1011
9%
44%
37%
10%
1%
53%
46%
DK
1045
39%
44%
13%
2%
1%
84%
15%
D-W
1053
25%
49%
19%
5%
1%
74%
25%
DE
1570
26%
50%
18%
5%
1%
76%
23%
D-E
517
31%
52%
14%
3%
0%
83%
17%
EE
1004
19%
52%
20%
5%
5%
70%
25%
EL
1000
81%
17%
1%
0%
0%
98%
2%
ES
1012
18%
53%
18%
6%
5%
70%
24%
FR1009
41%
48%
6%
3%
2%
89%
10%
IE1000
23%
44%
15%
12%
6%
67%
27%
I T1019
26%
58%
12%
4%
1%
84%
15%
CY
504
37%
46%
11%
2%
4%
83%
14%
LV1019
13%
51%
24%
8%
4%
64%
32%
LT1004
5%
31%
41%
20%
3%
36%
61%
LU506
41%
48%
7%
3%
1%
89%
10%
HU
1015
27%
48%
17%
7%
1%
75%
24%
MT
500
30%
44%
20%
5%
2%
74%
25%
NL
1019
24%
56%
16%
3%
1%
80%
19%
AT
1000
19%
49%
25%
5%
2%
68%
29%
PL1000
16%
50%
22%
9%
3%
66%
30%
P T1011
26%
53%
15%
5%
2%
78%
20%
SI
1027
18%
52%
22%
5%
2%
70%
27%
SK
1143
24%
54%
15%
5%
2%
78%
20%
FI1031
30%
57%
12%
1%
0%
87%
13%
SE
1002
36%
50%
11%
2%
1%
86%
13%
UK
1313
25%
54%
15%
4%
2%
79%
19%
BG
1025
16%
52%
15%
10%
6%
68%
25%
RO
1001
20%
37%
20%
15%
8%
57%
34%
The
resu
lts
of
the
rese
arch
(w
hat
is
know
n)
QC5.1
Cer
tain
asp
ects
of
bio
logic
al a
nd m
edic
al r
esea
rch m
ight
be
of
more
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
18%
47%
25%
8%
2%
65%
33%
BE
1032
22%
55%
18%
5%
0%
77%
22%
CZ
1011
6%
34%
45%
14%
1%
40%
59%
DK
1045
26%
50%
21%
2%
1%
75%
24%
D-W
1053
15%
42%
31%
10%
1%
57%
42%
DE
1570
15%
42%
32%
10%
1%
56%
43%
D-E
517
13%
41%
36%
9%
1%
54%
45%
EE
1004
11%
43%
33%
8%
5%
53%
41%
EL
1000
61%
25%
10%
4%
0%
85%
15%
ES
1012
11%
46%
25%
12%
6%
57%
37%
FR1009
31%
52%
11%
4%
2%
83%
15%
IE1000
16%
38%
24%
15%
7%
54%
39%
I T1019
19%
57%
19%
5%
1%
75%
24%
CY
504
23%
47%
19%
8%
4%
70%
26%
LV1019
7%
43%
34%
10%
5%
51%
44%
LT1004
3%
22%
48%
24%
4%
25%
71%
LU506
28%
49%
18%
4%
1%
77%
21%
HU
1015
11%
44%
31%
14%
1%
54%
45%
MT
500
25%
41%
26%
5%
3%
66%
31%
NL
1019
18%
50%
26%
4%
1%
68%
30%
AT
1000
14%
40%
33%
11%
3%
54%
44%
PL1000
9%
42%
32%
12%
4%
51%
44%
P T1011
18%
47%
26%
8%
2%
64%
34%
SI
1027
10%
42%
36%
9%
3%
53%
44%
SK
1143
13%
45%
30%
9%
2%
58%
40%
FI1031
14%
54%
27%
4%
1%
68%
31%
SE
1002
16%
45%
33%
5%
2%
60%
38%
UK
1313
18%
49%
25%
5%
3%
67%
30%
BG
1025
14%
40%
21%
16%
8%
54%
38%
RO
1001
11%
33%
29%
18%
9%
44%
47%
The
launch
ing o
f re
sear
ch p
roje
cts
and t
he
mai
n o
bje
ctiv
es o
f th
e re
sear
ch (
what
we
expec
t to
know
)
QC5.2
Cer
tain
asp
ects
of
bio
logic
al a
nd m
edic
al r
esea
rch m
ight
be
of
more
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
LV
ery
in
tere
sted
Fair
ly in
tere
sted
No
t very
in
tere
sted
No
t at
all in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
UE25 E
U25
24796
16%
41%
30%
10%
2%
57%
40%
BE
1032
15%
43%
33%
8%
0%
58%
41%
CZ
1011
5%
30%
46%
17%
2%
35%
64%
DK
1045
21%
39%
33%
6%
1%
60%
39%
D-W
1053
16%
37%
34%
11%
2%
53%
45%
DE
1570
15%
38%
35%
11%
2%
52%
46%
D-E
517
11%
41%
38%
10%
0%
52%
48%
EE
1004
10%
34%
41%
9%
6%
44%
50%
EL
1000
46%
31%
16%
6%
0%
77%
23%
ES
1012
10%
42%
29%
13%
6%
51%
42%
FR1009
26%
45%
20%
7%
3%
71%
26%
IE1000
17%
37%
22%
17%
8%
53%
39%
I T1019
15%
50%
27%
7%
1%
66%
33%
CY
504
21%
42%
23%
9%
5%
63%
32%
LV1019
7%
33%
39%
16%
6%
40%
55%
LT1004
3%
19%
49%
26%
4%
21%
74%
LU506
22%
49%
22%
5%
3%
71%
27%
HU
1015
11%
37%
35%
15%
1%
48%
50%
MT
500
19%
32%
37%
9%
3%
52%
46%
NL
1019
15%
40%
36%
8%
1%
55%
44%
AT
1000
14%
36%
35%
12%
2%
51%
47%
PL1000
7%
36%
38%
15%
4%
43%
53%
P T1011
16%
45%
29%
8%
2%
61%
37%
SI
1027
10%
39%
38%
10%
3%
49%
48%
SK
1143
12%
41%
34%
10%
3%
54%
44%
FI1031
14%
46%
32%
6%
1%
61%
38%
SE
1002
16%
39%
35%
8%
2%
55%
44%
UK
1313
19%
45%
28%
6%
3%
64%
34%
BG
1025
11%
33%
29%
19%
8%
44%
48%
RO
1001
10%
26%
30%
23%
10%
37%
53%
How
res
earc
her
s ar
e tr
ying t
o g
et t
his
know
ledge
(the
way
res
earc
h is
carr
ied o
ut)
QC5.3
Cer
tain
asp
ects
of
bio
logic
al a
nd m
edic
al r
esea
rch m
ight
be
of
more
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Rese
arc
her
s w
ork
ing
at
a
un
ivers
ity
or
go
vern
men
t la
bo
rato
ry
Med
ical
do
cto
rs o
r st
aff
Teach
ers
Co
lleag
ues,
fr
ien
ds
an
d
mem
bers
of
yo
ur
fam
ily
Go
vern
men
t (r
eg
ion
al,
n
ati
on
al)
Inte
rnati
on
al
inst
itu
tio
ns
(EU
, U
N
an
d its
h
ealt
h-
ded
icate
d
bo
die
s,
etc
.)
No
n
Go
vern
men
tal
Org
an
isati
on
s (N
GO
),
or
ass
oci
ati
on
s, s
uch
as
con
sum
er
ass
oci
ati
on
s, c
hari
ties,
p
ati
en
t o
r in
tere
st
gro
up
s
Sp
eci
alize
d
jou
rnalist
s w
riti
ng
in
sc
ien
ce o
r h
ealt
h
mag
azi
nes
TV
jo
urn
alist
s
Oth
er
jou
rnalist
s (n
ew
spap
er
s, r
ad
io,
mag
azi
ne)
No
ne
(SP
ON
TA
NE
OU
S)
Oth
ers
(S
PO
NTA
NE
OU
S)
DK
UE25 E
U25
24796
5%
47%
53%
10%
13%
10%
25%
19%
31%
19%
11%
2%
1%
4%
BE
1032
5%
63%
68%
13%
10%
13%
26%
16%
37%
20%
12%
1%
0%
0%
CZ
1011
4%
50%
51%
6%
14%
6%
27%
14%
34%
20%
9%
1%
- 4%
DK
1045
3%
73%
57%
6%
13%
14%
39%
28%
34%
10%
7%
2%
0%
1%
D-W
1053
5%
43%
54%
7%
17%
10%
30%
24%
40%
19%
14%
2%
1%
3%
DE
1570
6%
44%
54%
7%
16%
9%
30%
23%
41%
18%
14%
2%
1%
3%
D-E
517
9%
51%
57%
5%
12%
5%
30%
19%
43%
17%
14%
3%
1%
1%
EE
1004
4%
53%
51%
4%
12%
6%
20%
8%
36%
17%
14%
3%
0%
9%
EL
1000
5%
56%
71%
7%
15%
10%
23%
18%
40%
28%
7%
0%
1%
0%
ES
1012
2%
27%
46%
12%
11%
10%
14%
9%
16%
27%
10%
3%
2%
9%
FR1009
5%
58%
61%
11%
9%
9%
26%
29%
36%
21%
13%
2%
1%
2%
IE1000
9%
38%
52%
12%
20%
13%
25%
18%
28%
30%
21%
3%
1%
11%
I T1019
3%
46%
43%
6%
13%
12%
19%
17%
19%
16%
7%
1%
1%
3%
CY
504
5%
56%
65%
13%
19%
24%
37%
13%
30%
23%
10%
1%
0%
1%
LV1019
5%
38%
39%
6%
18%
5%
17%
5%
33%
29%
22%
4%
- 5%
LT1004
3%
47%
40%
6%
15%
5%
26%
7%
34%
25%
17%
4%
1%
7%
LU506
4%
54%
57%
8%
10%
12%
28%
18%
35%
26%
17%
2%
2%
3%
HU
1015
4%
38%
43%
7%
15%
9%
23%
10%
29%
30%
11%
5%
1%
5%
MT
500
2%
36%
73%
10%
23%
13%
24%
17%
27%
19%
9%
3%
1%
4%
NL
1019
6%
69%
63%
8%
12%
14%
34%
25%
47%
7%
11%
1%
0%
2%
AT
1000
9%
47%
63%
13%
20%
12%
21%
21%
32%
18%
14%
2%
1%
2%
PL1000
3%
41%
39%
22%
11%
3%
23%
11%
25%
22%
9%
3%
1%
9%
P T1011
5%
29%
61%
10%
8%
10%
24%
21%
30%
47%
16%
3%
- 4%
SI
1027
3%
41%
55%
10%
14%
4%
24%
18%
35%
18%
10%
3%
2%
3%
SK
1143
4%
58%
53%
8%
16%
5%
44%
21%
42%
17%
10%
1%
0%
2%
FI1031
4%
56%
64%
6%
10%
28%
38%
21%
37%
12%
12%
1%
0%
0%
SE
1002
7%
77%
56%
11%
14%
24%
38%
14%
44%
5%
6%
1%
1%
2%
UK
1313
10%
49%
57%
8%
16%
12%
27%
21%
30%
12%
9%
5%
0%
5%
BG
1025
2%
36%
61%
12%
19%
9%
29%
8%
26%
25%
9%
3%
0%
10%
RO
1001
7%
39%
63%
35%
22%
11%
31%
17%
33%
- -
- -
4%
QC6 W
hic
h f
our
of
the
follo
win
g c
ateg
ories
of
peo
ple
and o
rgan
izat
ions
would
you t
rust
more
when
it
com
es t
o info
rmat
ion a
bout
bio
logic
al a
nd m
edic
al r
esea
rch?
(MAX.
4 A
NSW
ERS)
TO
TA
L
Th
e d
aily lif
e
of
rese
arc
hers
w
ork
ing
on
th
is t
op
ic
Th
e
Go
vern
men
t d
eci
sio
ns
ab
ou
t th
e
rese
arc
h
New
d
isco
veri
es
Rese
arc
her’
s w
ork
on
th
e
risk
s o
f th
is
dis
ease
sp
read
ing
Deb
ate
s o
n
this
dis
ease
(c
au
ses,
tr
eatm
en
ts,
etc
.)
Sh
ow
ing
m
ate
rials
ab
ou
t th
e
rese
arc
h o
n
the d
isease
(l
ab
ora
tory
exp
eri
men
ts,
mo
vie
s sh
ow
ing
w
hat
the
dis
ease
m
akes
into
th
e b
od
y,
etc
.)
Rese
arc
h t
o
imp
rove
healt
h c
are
sy
stem
m
an
ag
em
en
t (e
.g.
in
ho
s pit
als
) fo
r th
is d
isease
Eth
ical is
sues
ab
ou
t th
is
rese
arc
h
Basi
c re
searc
h
lead
ing
to
n
ew
ap
pro
ach
es
No
ne
(SP
ON
TA
NEO
US
)
Oth
ers
(S
PO
NTA
NEO
US
) D
K
UE25 E
U25
24796
6%
15%
60%
34%
31%
19%
25%
11%
15%
3%
1%
4%
BE
1032
11%
18%
72%
40%
26%
18%
26%
11%
21%
2%
0%
0%
CZ
1011
6%
8%
47%
37%
37%
24%
22%
11%
12%
5%
0%
3%
DK
1045
8%
20%
72%
35%
43%
13%
30%
22%
19%
1%
0%
2%
D-W
1053
7%
16%
58%
41%
32%
23%
17%
9%
22%
3%
1%
5%
DE
1570
6%
16%
59%
41%
34%
23%
17%
9%
22%
3%
1%
5%
D-E
517
4%
13%
63%
42%
40%
24%
16%
10%
23%
3%
1%
1%
EE
1004
2%
7%
60%
34%
45%
22%
19%
9%
12%
3%
0%
9%
EL
1000
4%
8%
62%
37%
47%
31%
38%
18%
11%
0%
- 0%
ES
1012
3%
7%
64%
21%
24%
9%
17%
6%
7%
4%
2%
10%
FR1009
11%
21%
65%
40%
36%
20%
25%
16%
19%
1%
0%
3%
IE1000
7%
14%
52%
28%
27%
21%
38%
11%
19%
5%
1%
9%
I T1019
5%
21%
54%
27%
28%
17%
28%
12%
6%
2%
0%
3%
CY
504
5%
15%
71%
40%
54%
23%
27%
16%
11%
1%
- 2%
LV1019
3%
7%
52%
16%
29%
30%
27%
12%
19%
7%
- 5%
LT1004
11%
14%
46%
31%
30%
20%
18%
4%
17%
5%
1%
9%
LU506
9%
12%
59%
46%
43%
25%
27%
10%
14%
2%
0%
2%
HU
1015
4%
14%
54%
27%
27%
19%
27%
9%
15%
8%
0%
4%
MT
500
10%
15%
55%
26%
30%
21%
27%
11%
18%
5%
0%
5%
NL
1019
5%
12%
77%
40%
18%
26%
27%
19%
36%
0%
0%
2%
AT
1000
6%
17%
51%
40%
32%
25%
25%
14%
15%
5%
0%
4%
PL1000
4%
12%
51%
33%
33%
24%
16%
8%
9%
4%
0%
7%
P T1011
10%
12%
58%
31%
54%
17%
25%
9%
5%
5%
- 4%
SI
1027
4%
8%
64%
26%
41%
16%
22%
12%
10%
4%
2%
3%
SK
1143
7%
5%
54%
25%
52%
32%
34%
11%
17%
2%
- 3%
FI1031
9%
8%
67%
47%
35%
27%
31%
16%
11%
1%
1%
1%
SE
1002
7%
6%
71%
50%
28%
18%
46%
13%
31%
0%
0%
1%
UK
1313
6%
17%
65%
28%
23%
13%
36%
12%
17%
6%
- 4%
BG
1025
4%
10%
51%
55%
35%
24%
20%
7%
6%
4%
0%
9%
RO
1001
8%
10%
48%
33%
45%
21%
21%
5%
8%
4%
1%
14%
QC7 I
mag
ine
that
res
earc
h is
bei
ng d
one
on a
maj
or
dis
ease
. W
hat
asp
ects
of
this
res
earc
h w
ould
you b
e th
e m
ost
inte
rest
ed in?
(MAX.
3 A
NSW
ERS)
TO
TA
LY
es
No
DK
\ R
efu
sal (S
PO
NTA
NEO
US
)U
E25 E
U25
24796
50%
48%
2%
BE
1032
60%
39%
1%
CZ
1011
46%
52%
2%
DK
1045
65%
35%
0%
D-W
1053
53%
46%
1%
DE
1570
53%
46%
1%
D-E
517
55%
43%
1%
EE
1004
61%
37%
2%
EL
1000
29%
71%
0%
ES
1012
38%
60%
2%
FR1009
61%
39%
0%
IE1000
37%
60%
3%
I T1019
37%
56%
7%
CY
504
39%
60%
0%
LV1019
52%
47%
1%
LT1004
46%
52%
1%
LU506
38%
60%
1%
HU
1015
44%
55%
1%
MT
500
48%
51%
1%
NL
1019
81%
19%
0%
AT
1000
49%
44%
7%
PL1000
46%
54%
1%
P T1011
40%
59%
2%
SI
1027
40%
60%
1%
SK
1143
45%
55%
1%
FI1031
57%
43%
0%
SE
1002
69%
30%
1%
UK
1313
58%
41%
1%
BG
1025
29%
66%
5%
RO
1001
29%
65%
6%
QC8 H
ave
you o
r an
y of
your
love
d o
nes
, hav
e or
hav
e had
a c
hro
nic
dis
ease
(as
thm
a, d
iabet
es,
etc.
) or
a lif
e-th
reat
enin
g d
isea
se (
aids,
can
cer,
etc
.)?
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
47%
33%
10%
8%
2%
80%
18%
HR
1000
49%
39%
10%
2%
- 88%
12%
TR
1005
47%
33%
10%
8%
2%
80%
18%
Nat
ure
and t
he
envi
ronm
ent
QF1
.1 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
26%
32%
21%
18%
3%
58%
39%
HR
1000
26%
39%
26%
9%
- 65%
35%
TR
1005
26%
32%
20%
19%
3%
58%
39%
Eco
nom
ic a
nd s
oci
al m
atte
rs
QF1
.2 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
17%
22%
30%
28%
3%
39%
58%
HR
1000
17%
31%
34%
18%
- 48%
52%
TR
1005
16%
22%
30%
29%
3%
38%
59%
Art
and liter
ature
QF1
.3 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
18%
23%
27%
29%
3%
41%
56%
HR
1000
24%
39%
25%
12%
- 63%
37%
TR
1005
18%
22%
27%
30%
3%
40%
57%
Sci
ence
and t
echnolo
gy
QF1
.4 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
24%
23%
23%
27%
3%
47%
50%
HR
1000
31%
33%
22%
14%
- 64%
36%
TR
1005
24%
22%
23%
28%
3%
46%
51%
Sport
s an
d o
utd
oor
activi
ties
QF1
.5 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
20%
27%
26%
24%
3%
47%
50%
HR
1000
24%
38%
23%
14%
1%
62%
37%
TR
1005
20%
26%
26%
25%
3%
46%
51%
Med
ical
and h
ealth r
esea
rch
QF1
.6 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
42%
26%
16%
15%
1%
68%
31%
HR
1000
37%
35%
17%
11%
- 72%
28%
TR
1005
42%
25%
16%
15%
2%
67%
31%
Hom
e an
d g
arden
ing
QF1
.7 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
20%
26%
22%
29%
3%
46%
51%
HR
1000
20%
41%
24%
14%
1%
61%
38%
TR
1005
20%
26%
21%
30%
3%
46%
51%
Euro
pea
n a
nd inte
rnat
ional
new
s
QF1
.8 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
14%
20%
26%
37%
3%
34%
63%
HR
1000
15%
33%
29%
23%
- 48%
52%
TR
1005
14%
19%
26%
38%
3%
33%
64%
Cel
ebrities
and e
nte
rtai
nm
ent
QF1
.9 F
or
each
of th
e fo
llow
ing t
opic
s, p
leas
e te
ll m
e if y
ou a
re v
ery
inte
rest
ed,
fairly
inte
rest
ed,
not
very
inte
rest
ed,
or
not
at a
ll in
tere
sted
.
TO
TA
LY
es
No
PC 2
CC 2
2005
24%
76%
HR
1000
58%
42%
TR
1005
21%
79%
QF2
a In
(O
UR C
OU
NTRY),
ther
e ar
e re
sear
cher
s sp
ecia
lized
in b
iolo
gy
or
the
med
ical
sci
ence
s. H
ave
you e
ver
hea
rd o
f an
y of th
em w
ork
ing o
n c
olla
bora
tive
res
earc
h p
roje
cts
with c
olle
agues
fro
m o
ther
Euro
pea
n c
ountr
ies,
or
hav
ing t
he
poss
ibili
ty t
o d
o s
o?
TO
TA
LY
es
No
PC 2
CC 2
2005
13%
87%
HR
1000
54%
46%
TR
1005
10%
90%
QF2
b A
nd h
ave
you e
ver
hea
rd o
f th
e Euro
pea
n U
nio
n fundin
g a
ny
colla
bora
tive
res
earc
h p
roje
cts
on b
iolo
gy
or
med
ical
sci
ence
iss
ues
?
TO
TA
LY
ou
were
giv
en
th
is
info
rmati
on
exp
lici
tly
Yo
u d
ed
uce
d t
his
yo
urs
elf
fro
m o
ther
info
rmati
on
yo
u r
ece
ived
Yo
u c
am
e a
cro
ss t
his
in
form
ati
on
wh
en
se
arc
hin
g f
or
info
rmati
on
on
sci
en
ces,
re
searc
h o
r m
ed
icin
e
No
ne (
SP
ON
T.)
Oth
ers
(S
PO
NT.)
DK
PC 2
CC 2
260
27%
22%
25%
6%
16%
4%
HR
538
26%
45%
17%
2%
8%
2%
TR
98
27%
11%
29%
8%
20%
5%
(IF
'AW
ARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U', C
OD
E 1
IN
QF2
b)
QF3
a Could
you p
leas
e te
ll m
e th
e m
ost
com
mon w
ay y
ou h
eard
about
thes
e Euro
pea
n U
nio
n funded
pro
ject
s in
the
fiel
d o
f bio
logic
al a
nd m
edic
al r
esea
rch?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he c
on
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
ali
zed
m
ag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
ers
Th
e I
nte
rnet
Oth
ers
(S
PO
NT.)
DK
PC 2
CC 2
260
4%
4%
9%
13%
5%
12%
9%
15%
77%
17%
46%
24%
2%
3%
HR
538
1%
2%
9%
15%
3%
4%
11%
11%
90%
28%
61%
19%
0%
0%
TR
98
4%
4%
8%
12%
5%
15%
9%
16%
72%
12%
40%
26%
2%
5%
(IF
'AW
ARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U', C
OD
E 1
IN
QF2
b)
QF4
a Am
ong t
he
follo
win
g,
what
wer
e yo
ur
mai
n s
ourc
es o
f th
is info
rmat
ion?
(MAX.
4 A
NSW
ERS)
TO
TA
LY
ou
are
in
tere
sted
in
sc
ien
ce o
r m
ed
icin
e,
bu
t n
ot
in t
he d
eta
ils
Yo
u a
re n
ot
inte
rest
ed
in
Eu
rop
ean
matt
ers
Yo
u d
id n
ot
com
e a
cro
ss
this
in
form
ati
on
th
rou
gh
yo
ur
usu
al
sou
rces
of
info
rmati
on
on
sci
en
ce
or
med
icin
e
No
ne (
SP
ON
T.)
Oth
ers
(S
PO
NT.)
D
K
PC 2
CC 2
944
42%
14%
14%
12%
3%
15%
HR
293
33%
11%
40%
1%
1%
14%
TR
487
42%
14%
12%
13%
4%
15%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U,
BU
T I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
/OR M
ED
ICAL
RESEARCH
', C
OD
E 2
IN
QF2
b A
ND
CO
DE 1
OR 2
IN
QF1
_4 O
R Q
F1_6)
QF3
b A
lthough y
ou a
re inte
rest
ed in s
cien
ce a
nd\
or
med
ical
and h
ealth r
esea
rch,
among t
he
follo
win
g,
what
is
the
mai
n r
easo
n w
hy
you h
aven
’t h
eard
of an
y EU
-funded
pro
ject
s in
thes
e fiel
ds?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he
con
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
ali
zed
m
ag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
ers
Th
e
Inte
rnet
Oth
ers
(S
PO
NT.)
DK
PC 2
CC 2
944
2%
5%
2%
10%
5%
17%
5%
7%
70%
14%
33%
11%
2%
12%
HR
293
0%
1%
5%
14%
3%
8%
7%
9%
80%
22%
40%
14%
1%
12%
TR
487
2%
5%
2%
10%
5%
17%
5%
7%
70%
13%
33%
11%
2%
12%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U,
BU
T I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
/OR M
ED
ICAL
RESEARCH
', C
OD
E 2
IN
QF2
b A
ND
CO
DE 1
OR 2
IN
QF1
_4 O
R Q
F1_6)
QF4
b A
mong t
he
follo
win
g,
what
are
your
mai
n s
ourc
es o
f in
form
atio
n o
n s
cien
ce,
or
med
ical
and h
ealth r
esea
rch?
(MAX.
4 A
NSW
ERS)
TO
TA
LY
ou
have n
o i
nte
rest
in
sc
ien
ce i
n g
en
era
l
Yo
u d
o n
ot
feel
con
cern
ed
, as
yo
u a
re i
n
go
od
healt
h
Yo
u d
o n
ot
tru
st t
he
sou
rces
of
info
rmati
on
o
n t
hese
su
bje
cts
No
ne (
SP
ON
TA
NEO
US
) O
thers
(S
PO
NTA
NEO
US
) D
K
PC 2
CC 2
738
59%
9%
4%
8%
4%
16%
HR
167
64%
7%
12%
3%
5%
9%
TR
386
59%
9%
4%
8%
4%
16%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U,A
ND
NO
T I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
MED
ICAL
RESEARCH
', C
OD
E 2
IN
QF2
b A
ND
CO
DE 3
OR 4
IN
QF1
_4 A
ND
QF1
_6)
QF3
c Could
you p
leas
e te
ll m
e, a
mong t
he
follo
win
g,
what
is
the
mai
n r
easo
n w
hy
you a
re n
ot
inte
rest
ed in s
cien
ce a
nd in m
edic
al o
r hea
lth r
esea
rch?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sc
ien
ce
exh
ibit
ion
s)
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Co
lleag
ues
or
in t
he
con
text
of
yo
ur
wo
rk
Fri
en
ds
or
mem
bers
of
yo
ur
fam
ily
Teach
ers
Med
ical
do
cto
rs o
r st
aff
Sp
eci
ali
zed
m
ag
azi
nes,
o
n y
ou
r su
bje
cts
of
inte
rest
(i
ncl
ud
ing
sc
ien
ce o
r h
ealt
h
mag
azi
nes)
Gen
era
l m
ag
azi
nes,
su
ch a
s n
ew
s m
ag
azi
nes,
TV
m
ag
azi
nes,
etc
.
Tele
vis
ion
Rad
ioN
ew
spap
ers
Th
e
Inte
rnet
Oth
ers
(S
PO
NT.)
DK
PC 2
CC 2
738
1%
9%
3%
13%
2%
13%
2%
3%
68%
11%
24%
3%
1%
16%
HR
167
1%
- 10%
31%
1%
2%
2%
3%
84%
21%
33%
6%
1%
6%
TR
386
1%
9%
2%
12%
2%
13%
2%
3%
68%
11%
24%
3%
1%
16%
(IF
'NO
T A
WARE O
F PR
OJE
CTS F
UN
DED
BY T
HE E
U,A
ND
NO
T I
NTERESTED
IN
TH
E F
IELD
S O
F SCIE
NCE A
ND
MED
ICAL
RESEARCH
', C
OD
E 2
IN
QF2
b A
ND
CO
DE 3
OR 4
IN
QF1
_4 A
ND
QF1
_6)
QF4
c Am
ong t
he
follo
win
g,
what
are
your
mai
n s
ourc
es o
f in
form
atio
n o
n y
our
subje
cts
of in
tere
st?
(MAX.
4 A
NSW
ERS)
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
24%
29%
19%
18%
10%
53%
37%
HR
1000
31%
45%
16%
7%
1%
76%
23%
TR
1005
24%
28%
19%
18%
11%
52%
37%
The
resu
lts
of th
e re
sear
ch (
what
is
know
n)
QF5
.1 W
ithin
bio
logic
al a
nd m
edic
al r
esea
rch,
cert
ain a
spec
ts m
ight
be
of m
ore
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
17%
25%
25%
22%
11%
42%
47%
HR
1000
25%
43%
22%
9%
1%
68%
31%
TR
1005
16%
24%
25%
23%
12%
40%
48%
The
launch
of re
sear
ch p
roje
cts
and t
he
mai
n o
bje
ctiv
es o
f th
e re
sear
ch (
what
we
expec
t to
know
)
QF5
.2 W
ithin
bio
logic
al a
nd m
edic
al r
esea
rch,
cert
ain a
spec
ts m
ight
be
of m
ore
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
LV
ery
in
tere
sted
Fair
ly i
nte
rest
ed
No
t very
in
tere
sted
No
t at
all
in
tere
sted
D
KIn
tere
sted
No
t in
tere
sted
PC 2
CC 2
2005
19%
20%
25%
24%
12%
39%
49%
HR
1000
23%
41%
25%
10%
1%
64%
35%
TR
1005
18%
19%
26%
25%
12%
37%
51%
How
res
earc
her
s ar
e tr
ying t
o g
et t
his
know
ledge
(the
way
res
earc
h is
carr
ied o
ut)
QF5
.3 W
ithin
bio
logic
al a
nd m
edic
al r
esea
rch,
cert
ain a
spec
ts m
ight
be
of m
ore
inte
rest
to y
ou.
How
inte
rest
ed a
re y
ou in e
ach o
f th
e fo
llow
ing?
TO
TA
L
Mu
seu
ms,
exh
ibit
ion
s o
r fe
stiv
als
(i
ncl
ud
ing
sci
en
ce
exh
ibit
ion
s)
Rese
arc
hers
w
ork
ing
at
a
un
ivers
ity o
r g
overn
men
t la
bo
rato
ry
Med
ical
do
cto
rs o
r st
aff
Teach
ers
Co
lleag
ues,
fr
ien
ds
an
d
mem
bers
of
yo
ur
fam
ily
Go
vern
men
t (n
ati
on
al
or
reg
ion
al)
Inte
rnati
on
al
inst
itu
tio
ns
(EU
, U
N a
nd
it
s h
ealt
h-
ded
icate
d
bo
die
s, e
tc.)
No
n
Go
vern
men
tal
Org
an
isati
on
s (N
GO
), o
r ass
oci
ati
on
s,
such
as
con
sum
er
ass
oci
ati
on
s,
chari
ties,
p
ati
en
t o
r in
tere
st g
rou
ps
Sp
eci
ali
zed
jo
urn
ali
sts
wri
tin
g i
n
scie
nce
or
healt
h
mag
azi
nes
TV
jo
urn
ali
sts
Oth
er
jou
rnali
sts
(new
spap
ers
, ra
dio
, m
ag
azi
ne)
No
ne
(SP
ON
T.)
O
thers
(S
PO
NT.)
D
K
PC 2
CC 2
2005
2%
27%
51%
11%
11%
15%
12%
8%
13%
11%
4%
4%
1%
12%
HR
1000
2%
57%
51%
6%
15%
4%
23%
21%
26%
18%
5%
2%
0%
6%
TR
1005
2%
25%
51%
11%
10%
16%
11%
7%
12%
11%
4%
4%
1%
12%
QF6
Whic
h four
of th
e fo
llow
ing c
ateg
ories
of peo
ple
and o
rgan
izat
ions
would
you t
rust
most
when
it
com
es t
o info
rmat
ion a
bout
bio
logic
al a
nd m
edic
al r
esea
rch?
(MAX.
4 A
NSW
ERS)
TO
TA
L
Th
e d
aily l
ife
of
rese
arc
hers
w
ork
ing
on
th
is t
op
ic
Th
e
Go
vern
men
t d
eci
sio
ns
ab
ou
t th
e
rese
arc
h
New
d
isco
veri
es
Rese
arc
hers
' w
ork
on
th
e
risk
s o
f th
is
dis
ease
sp
read
ing
Deb
ate
s o
n
this
dis
ease
(c
au
ses,
tr
eatm
en
ts,
etc
.)
Sh
ow
ing
m
ate
rials
ab
ou
t th
e
rese
arc
h o
n
the d
isease
(l
ab
ora
tory
exp
eri
men
ts,
mo
vie
s sh
ow
ing
w
hat
the
dis
ease
do
es
to t
he b
od
y,
etc
.)
Rese
arc
h t
o
imp
rove
healt
h c
are
sy
stem
m
an
ag
em
en
t (e
.g.
in
ho
spit
als
) fo
r th
is d
isease
Eth
ical
issu
es
ab
ou
t th
is
rese
arc
h
Basi
c re
searc
h
lead
ing
to
n
ew
ap
pro
ach
es
No
ne
(SP
ON
T.)
O
thers
(S
PO
NT.)
D
K
PC 2
CC 2
2005
5%
14%
39%
31%
26%
25%
15%
4%
3%
4%
0%
12%
HR
1000
7%
6%
64%
37%
44%
16%
15%
15%
7%
2%
0%
5%
TR
1005
4%
15%
37%
31%
24%
25%
15%
4%
2%
4%
0%
12%
QF7
Im
agin
e th
at r
esea
rch is
bei
ng d
one
on a
maj
or
dis
ease
. W
hat
asp
ects
of th
is r
esea
rch w
ould
you b
e th
e m
ost
inte
rest
ed in?
(MAX.
3 A
NSW
ERS)
TO
TA
LY
es
No
DK
\ R
efu
sal
(SP
ON
TA
NEO
US
)PC
2 C
C 2
2005
34%
64%
2%
HR
1000
36%
63%
1%
TR
1005
34%
64%
2%
QF8
Do y
ou o
r an
y of yo
ur
love
d o
nes
, hav
e or
hav
e had
a c
hro
nic
dis
ease
(as
thm
a, d
iabet
es,
etc.
) or
a lif
e-th
reat
enin
g d
isea
se (
aids,
can
cer,
etc
.)?
SALES AND SUBSCRIPTIONS
Publications for sale produced by the Office of Official Publications of the European Communities are available from our sales agents throughout the world.
You can find the list of sales agents on the Publications Office website (http://publications.europa.eu) or you can apply for it by fax (352) 29 29-42758.
Contact the sales agent of your choice and place your order.
European Commission
EUR 22970 — Medical and Health Research — A special Eurobarometer public survey
Luxembourg: Office for Official Publications of the European Communities
2007 — 116 pp. — 29.7 x 21 cm
ISBN 978-92-79-06625-2
The European Commission has carried out a Eurobarometer public opinion survey to analyse the degree of interest and information European citizens have about medical and health research. In particular, this study aims to measure the level of awareness among European citizens of European collaborative research projects on biological and medical issues, and to identify the factors and sources of information that can contribute to improving such awareness.
Nearly 29,000 interviews were performed in 27 European countries, from mid to late 2006, and the results were analysed in 2007. The present report sets out the study’s main conclusions:
Europeans have a strong interest in biological and medical research, particularly regarding the added value that the results of such research can contribute to their daily lives. Around half of Europeans are aware that researchers specialised in biology or medical sciences have the opportunity to work with European colleagues on collaborative research projects.
Citizens trust the scientific and medical professions above all others when it comes to information on science or biological and health research, followed by the specialised press. International institutions -including the EU- and non-governmental organisations are significantly more trusted than regional or national governmental sources.
Television remains the most important information channel, followed by newspapers, radio and magazines. The growing use of the internet as a source of scientific information, especially among young Europeans, should also be taken into account.
•
•
•
KI-N
A-22970-EN
-S